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Summary 
The study o f sterol defective mutants o f Arabidopsis thaliana has provided an 
invaluable opportunity to investigate the importance o f sterols in plant development. 
The hydra mutants in particular - seedling lethal mutations - exhibit great phenotypic 
variation, leading to the supposition that sterols have a far more complex role in plant 
development than previously anticipated. 
It has been postulated that some sterol molecules are directly involved in the 
regulation o f gene transcription during plant development. The binding o f some 
sterols to START domains (sterol binding domains) found in some mammalian 
proteins has been noted, and it is possible that plant transcription factors containing 
START domains could be localised to the nucleus by the binding o f specific sterols. 
This hypothesis may be tested by creating HD-START::GFP fusion proteins to act as 
a reporter, permitting the subcellular localisation o f the produced protein to be viewed 
using confocal scanning laser microscopy. 
In order to determine i f the expression o f START domain transcription factors is itself 
regulated by sterols, independent o f possible roles for sterols in their localization to 
the nucleus, the comparative steady state transcription levels o f five HD-START 
domain transcription factors were studied by real-time RT-PCR. A comparison o f 
hydra mutant mRNA levels to their wi ld type counterparts was carried out to 
determine whether there is a requirement for sterols in the regulation o f the tested 
genes. Although the results do appear to suggest this to be the case, the data and the 
conclusions require further validation. 
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1. Introduction 
1.1. Background Information 
The regulation o f genes and their activity is a very important component in the 
development o f all l iving creatures. Genes regulate all functions in development and 
indeed throughout l i fe; many genes also regulate the activity o f other genes, perhaps 
the most classic example being those coding for transcription factors required for the 
expression o f other genes. 
1.1.1. Sterols and the Sterol Biosynthetic Pathway 
1.1.1.1. Sterols 
Sterols are essential molecules in all eukaryotes, playing a crucial role in many 
aspects o f cellular activity. They play a key structural role, with their presence in 
membranes allowing for increased and regulated fluidity which is essential for cells to 
function, allowing the modulation o f protein function and preventing membrane 
freezing at low temperatures. They also play an important role in both extracellular 
and intracellular signalling, often acting as secondary messengers, and are precursors 
of a number o f other molecules. Ergosterol, typically found in fungal cell membranes, 
can go on to form Vitamin D 2 with the aid o f ultraviolet light (Rajakumar, 2007). In 
plants sterols take on an extra significance as the precursors o f the hormones known 
collectively as brassinosteroids (BR) (Hartmann, 1998). The BRs are involved in any 
plant processes, including the promotion o f vascular differentiation (Cano-Delgado, 
2004), pollen tube formation (Hewitt etal., 1985) and, alongside auxin, the promotion o f 
cell elongation and expansion (Clouse and S a s s e , 1998; Nemhauser ef a/., 2004) 
Therefore it is diff icul t to overestimate the importance o f sterols in plants, and much 
work has been carried out in order to elucidate the mechanisms by which they are 
formed, transported, and function (Bishop and Yokota, 2001). 
1.1.1.2. The Sterol Biosynthetic Pathway 
Since the functions o f sterols are clearly so many and varied, it is important to 
understand how the molecules themselves are made. In plants the pathway by which 
sterols are produced is complex, involving many reaction steps and a multitude o f 
enzymes. Such complexity can be beneficial to the plant, since it allows for a great 
diversity o f products and also allows for tight regulation by the many enzymes and 
other molecules involved at each step. 
Figure 1 shows a simplified representation o f the sterol biosynthetic pathway in 
Arabidopsis thaliana. It is evident that much of the pathway is arranged as steps 
which fol low directly on f rom one another. It is also evident f rom the diagram that the 
Arabidopsis sterol biosynthetic pathway forks into two major and distinct branches, 
each o f which leads to the production o f very different products. One branch primarily 
synthesises those sterols which have roles in membrane f luidi ty (such as cholesterol) 
and intracellular signalling (i.e. the bulk sterols). The second branch, whilst forming 
other sterols early on, ultimately goes on to form the brassinosteroid hormones, 
(Hartmann,1998; Clouse, 2000). 
1.1.1.3. Mutations in the Sterol Biosynthesis Pathway 
Much o f the sterol biosynthesis pathway and many of the enzymes involved with it 
have been identified and characterised based on comparison with the sterol 
biosynthetic pathway in yeast, which has been well studied (Gachotte et al., 1996). 
Studies in plants themselves have yielded a wealth o f information, and genetic studies 
have proved valuable in identifying enzymes involved in the production o f sterols and 
further understanding signal transduction (Clouse, 2000; Diener et al., 2000; Schaeffer et 
al., 2001). In such a highly complex pathway there are a large number o f enzymes and 
other molecules required in order for the pathway to function. Any one o f the steps, i f 
affected by a non-redundant mutation, would prevent the formation o f sterols essential 
to the development of a healthy plant. 
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Figure 1: Diagrammatic representation of the sterol biosyntlietic pathway in Arabidopsis 
(from Schrick, 2002) showing the relative positions of the hj/dra 1-2 and hi/dra 2 (also 
known as facAe/, and marked above as FK) mutants. It should be noted that the hj/dra 
mutations are located upstream of the division of the pathway into two main branches, 
and consequently the hydra mutations would affect the bulk sterols and the 
brassinosteriods. fhttp://\^T^w.Tjni4uebingen.de/ZMBP/reseaich/dgschnck.htmri 
Numerous mutations which affect the Arabidopsis sterol biosynthetic pathway have 
already been identified, and the study o f mutants such as these has proved a valuable 
tool in further elucidating the mechanisms by which plant development is governed. 
Some defects in embryogenesis and hormone signalling appear to be the result o f 
abnormal sterol levels, and in some cases the application o f a sterol, otherwise 
downregulated by a particular mutation, results in at least partial phenotype rescue. 
Typically this phenotype rescue is possible when an enzyme involved in the BR 
branch o f the sterol biosynthesis pathway is faulty, where the exogenous application 
of BRs allows the plant to develop far more normally than would otherwise have been 
possible (Szekeres etal., 1996; C h o e etal., 1999), as is the case with the tomato dwarf 
mutants, with a mutation directly affecting the mutation o f the BR brassinolide 
(Bishop et a/., 1999). However, many other mutations are unable to be overcome by the 
addition o f BRs. One such mutant is the Arabidopsis mutant sterol methyltransferase 
1 {smtl), in which sitosterol is not formed (Diener ef a/., 2000). 
Another sterol biosynthetic mutant which was unable to be rescued by exogenous BR 
application, despite being BR deficient, was fackel (/it). Encoding a sterol reductase 
the fk mutants are typically embryonic lethal, although they are able to be grown for a 
time in MS media (Jang et a!., 2000; Schrick et a!., 2000). Further studies have since 
shown that FK is allelic to the hydra2 {hyd2) mutant, first described along with hydl 
in 1997 (Topping, 1997). It is these hydra mutants which w i l l be studied in further 
detail in this dissertation. 
1.1.2. The/rjrfra Mutants 
The sequential organisation o f the Arabidopsis sterol biosynthesis pathway is such 
that a mutation further upstream in the sequence would affect many sterols located 
further downstream, likely resulting in pleiotropic phenotypes. Such is the case with 
the Arabidopsis mutants hydral and hydral, where the mutations affect steps o f the 
biosynthetic pathway upstream o f the fork which splits the pathway into the bulk 
steroid and BR branches (Diener ef a/. 2000; Jang ef a/. 2000; Schrick ef a/. 2000; 2002; 
Souter ef a/. 2002) . These mutants therefore suggest a critical role for sterols in 
signalling pathways involved in early plant development and patterning. 
1.1.2.1. The hydra Mutant Phenotype 
The hydra mutants were first identified by a mutational screen in 1997, and were 
found to contain significantly reduced concentrations o f major sterols than the wi ld 
type. The resulting pleiotropic phenotypes were highly variable. Generally seedling 
lethal, these mutants were dwarfed, characterised by misshaped cells, multiple, fused 
cotyledons, a truncated hypocotyl, and a greatly reduced root system. I f grown in 
greenhouse conditions these mutants are embryonic lethal, because although embryo 
development is completely normal up to the octant stage, the embryos rapidly fal l 
behind what is expected from the wi ld type in terms o f cellular arrangement, with 
very poorly defined vascular tissue and embryonic root when present at all (Topping et 
a/., 1997). Figure 2 shows a wi ld type seedling as compared with a hydra mutant 
(pictured at 3 weeks old). 
1.1.2.2. The hydra Mutations 
The mutations which cause the hydl and hyd2 phenotypes have been identified, 
allowing a greater understanding o f the roles o f the HYDl and HYD2 genes in sterol 
biosynthesis. HYDRA 1 is a gene which encodes a A7- A8 sterol isomerase enzyme 
first characterised in yeast (Grebenok, 1998). There are no similar mutants in other 
organisms, although the protein itself has been found to have much homology with 
EBP, a mammalian sterol receptor located in the nuclear envelope and endoplasmic 
reticulum o f cells (Jblio et a/., 1997; D u s s o s s o y ef a/., 1999). The HYDRA2 gene has 
been identified as coding for a C14 sterol isomerase located 1 step upstream from 
HYDRA 1 in the sterol biosynthesis pathway. 
1.1.2.3. What the hydra Mutants Can Teach Us 
The study o f the pleiotropic effects o f two identifiable mutations which occur in such 
close proximity within the sterol biosynthetic pathway, provides further evidence 
which may be used to determine possible mechanisms by which sterols are involved 
in plant development. 
B) 
Figure 2 : A typical Arabidopsis plant (A) as compared with a h}/dra 
mutant (B) both aged three weeks. In the images above the h\/dra mutant 
has been magnified x4, whereas the wild type plant has been magnified 
x2. Here the truncated shape exhibited by hydra mutants is visible, as well 
as atypical cotyledons, however the exact phenotype of hydra mutants is 
highly variable. 
As mentioned previously, the hydra mutants, while low in BRlevels, cannot be 
rescued by the exogenous application o f BRs. Since other mutants can be rescued, 
whether ful ly or partially, by this method, the unresponsiveness o f the hyd mutants is 
suggestive o f difficulties either in perceiving or utilising the BRs applied or o f a role 
for sterols upstream of the BR pathway. This in turn indicates that the problems 
encountered by the hyd mutants during development are not purely the result o f a lack 
of BRs, and therefore it is likely that some bulk sterols, or indeed minor sterols, may 
have important roles to play in plant development. 
Whilst it is possible that a failure to respond to applied BRs is the result o f decreased 
membrane permeability or similar problems, another possible mechanism is being 
investigated which could shed ftirther light on the varied and complex sterol 
interactions required for development. 
1.1.3 S T A R T Domain Genes 
1.1.3.1. What S T A R T Domain Proteins Are 
START domains are sterol binding regions found in some proteins and are 
approximately 2 0 0 amino acids in length. They are highly conserved in plants and 
animals and appear to have a regulatory role (Ponting and Aravind 1999; Schrick ef a/. 
2004). 
Proteins with this sterol binding region were first identified in mammals, which make 
use o f a protein which binds and transports cholesterol. This cholesterol binding 
protein is known as the steroidogenic acute regulatory protein (StAR) and problems 
with the expression or function o f this protein are known to result in a variety o f 
disorders in humans, including autoimmune diseases and some cancers ( r ev iewed in 
Alpy a n d T o m a s e t t o 2 0 0 5 ) . 
The StAR-related lipid transfer (START) domains were again first identified in 
mammals, where the structure o f several START domains has been determined. The 
evidence shows they form a hydrophobic tunnel into which a ligand, typically a sterol 
but may also be a lipid, is bound (Schrick, 2006). START domain proteins are far more 
numerous in plants than in mammals, wi th the human genome containing 15 as 
opposed to the 36 found in Arabidopsis. This dissertation w i l l be focusing upon the 
START domain proteins found in plants, where they are thought to play a role in 
signalling and transport 
Several theories for START-mediated l ipid signalling have been proposed, and many 
different families o f START domain proteins have been identified and investigated. 
Amongst these families are those START domain proteins which also contain a 
pleckstrin homology (PH) domain, whose fimction appears to be linked to 
phospholipid signalling and at least one o f which is implicated in disease resistance 
(encountered in studies o f faciogenital dysplasia, or Aarskag-Scott Syndrome: Orrico, 
2000). There are also two families o f START domain proteins specific to plants 
which contain a C-terminal domain designated DUF1336, the function o f which has 
not yet been determined. (Schrick, 2006). The family o f START domain proteins to be 
considered and studied in more depth in this dissertation are the plant-specific family 
which contain both a START domain and a homeodomain (HD) D N A binding motif. 
1.1.3.2. The Role of Sterols in H D - S T A R T Domain Transcription 
Factors 
In Arabidopsis the majority o f proteins containing a START domain also contain this 
HD motif and act as transcription factors. The HD-START transcription factor family 
were found through genetic analyses to be involved in plant development. This 
evidence, added to the knowledge that mutant HD-START phenotypes exhibit 
phenotypic similarities with a select group of sterol biosynthesis mutants, supports the 
hypothesis that the START domains in transcription factors have some role to play in 
regulating the expression o f genes and therefore plant development as well . 
More specifically, a subset o f the HD-START domain proteins has been characterized 
which should contain a leucine zipper, a structural motif in proteins which allows the 
arrangement o f parallel alpha helices. This HD-ZIP subset o f START domain 
transcription factors has been divided into 2 families, each o f which contains genes 
which wi l l be studied further in this investigation. Of the 21 HD-START domain 
transcription factors in Arabidopsis, 16 contain what is known as the class IV H D 
Leu-zipper (HD-ZIP) and therefore form the class IV HD-ZIP family (Schrick, 2006). 
A number o f these HD-START proteins containing the IV HD-ZIP region are known 
to be involved in development, allowing for cell differentiation within specific layers 
of tissue ( r e v i e w e d in S c h r i c k et al. 2 0 0 4 ) . Two members o f this family have been 
chosen for further study: Arabidopsis thaliana MERISTEMLAYER 1 {AtMLl), 
expressed in the epidermis of developing embryos, and GLABRA 2 {GL2), affecting 
epidermal cell fate, including trichomes, root hairs, and seed coat (Nakamura ef al. 
2006). 
The remaining 5 HD-START domain transcription factors form the class I I I HD-ZIP 
family, in which the products contain a classic basic-region leucine zipper (Mukherjee 
etal. 2006). O f these five genes, three w i l l be investigated further during this 
dissertation: REVOLUTA (REV), involved in meristem formation at lateral positions 
such as lateral roots and flower buds, and PHABULOSA (PHB) and PHA VOLUTA 
(PHV), both o f which have been implicated in regulating abaxial/adaxial axis fate in 
developing leaves. A l l o f these genes in the class I I I HD-ZIP family have roles in 
embryonic patterning, and their roles have been found partially to overlap (Prigge ef 
al., 2005) 
Therefore five different genes have been chosen for study: AtMLl, GL2, PHB, PHV, 
and REV. These genes were all chosen because they all have roles in patterning and 
cell fate during development. It is hypothesised that sterols interact with them and 
may therefore help to regulate or aid their function, in which case sterols would have 
a key regulatory role in plant development ( M c C o n n e l l et a/., 2 0 0 1 ) . 
1.2. The Project: Aims and Objectives 
The overall aim of this project is to elucidate further the critical role played by sterols 
in plant development. It has been hypothesized that the extreme pleiotropic phenotype 
exhibited by hydra mutants is a direct result of the role of sterols in gene regulation. 
The mutations involved may result in a lack of specific sterols required to allow some 
plant transcription factors to function, either acting as co-factors or as ligands. There 
are 36 proteins in Arabidopsis which are thought to contain a sterol binding site (a 
START domain), and the majority are either known or predicted to be transcription 
factors. The working hypothesis for this project is that the binding of sterol molecules 
to START domains of the transcription factors acts to regulate gene expression by 
targeting the protein-sterol complex to the nucleus, where the transcription factor may 
carry out its function. Were this hypothesis to be correct, the hydra mutants could be 
the result of a deficiency of specific sterols resulting in improper subcellular 
localization or activity of START domain transcription factors, leaving them unable 
to carry out their function and therefore the developmental genes which they regulate 
would not be expressed. Given the phenotypic defects in the hydra mutants, it is also 
possible that transcription factors, including START-domain transcription factors, are 
not correctly expressed in the mutants, a possibility that is distinct from the possible 
mis-localization of these proteins. 
The role of this dissertation is therefore to attempt to further the bodies of evidence 
enable the understanding of two important processes: 
1.2.1. The Regulation of START Domain Transcription Factors 
In order to determine i f the expression of START domain transcription factors are in 
some way misregulated in sterol mutants, the comparative transcription levels of the 
five HD-START domain transcription factors described earlier - AtMLl, GL2, PHB, 
PHVand REV- are here determined by real-time RT-PCR. This was accomplished by 
isolating mRNA from developing seedlings at 2 day intervals, thus their steady state 
transcription levels could be analysed in both hydra mutant backgrounds over the a 
14 day developmental period as compared with wild type. Any significant differences 
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between steady state transcription levels of the genes in question in a typical sterol 
environment versus an atypical sterol environment would likely indicate a 
requirement for sterols. 
1.2.2. The Subcellular Localisation of START Domain Transcription 
Factors 
A major hypothesis of this dissertation is that sterols, by binding to START domain 
transcription factors, target them to the nucleus where they are then able to regulate 
gene expression, it follows that transcription factors expressed in an atypical sterol 
background might be improperly localised such that they would be present in the cell 
cytoplasm, and this can be tested. It is possible to determine this localisaton by 
creating HD-START::GFP fusion proteins to act as an indicator enabling the 
subcellular localization of a specific transcription factor to be observed when samples 
are viewed using confocal scanning laser microscopy. In this case the GFP to be used 
was the pMP N-linked GFP fiision construct,described in section 1.3.1.1., within the 
alcohol inducible binary vector described in section 1.3.1.2. 
1.3. Methods to be Used 
1.3.1 GFP and the ale System 
1.3.1.1. GFP as an Experimental Tool 
Green Fluorescent Protein, or GFP, is a protein of 238 amino acids which fluoresces 
green when exposed to blue light (Tsien, 1998). It was first identified in the jellyfish 
Aequorea victoria in 1962 (Shimomura etal., 1962) and its discovery and scientific 
applications have proven so important that the scientists involved in its identification 
have been awarded a Nobel Prize for their achievements. However, the true 
significance of their discovery was not immediately evident, and it was not until some 
years later that the potential of GFP as a reporter for use in molecular biology studies 
began to be realised. This was largely made possible by the publication of a 
nucleotide sequence for wild type GFP (Prasher et al., 1992) along with the fact that 
GFP requires no additional chemicals to fluoresce, and is able to fluoresce at room 
temperature. GFP has been adapted to a wide range of uses in molecular biology, 
though in each case it acts as a reporter, providing information on the location of the 
protein(s) to which it is bound. This reporting can be large scale, allowing detection of 
specific cell types in vivo (Chudakov et al. 2005) or, on a smaller scale, it has been used 
to facilitate further understanding of processes such as protein folding and transport. 
GFP has proven to be invaluable in laboratory studies, revolutionising fluorescence 
microscopy and enabling previously very challenging experiments to be carried out 
more easily and effectively than previously (Yuste, 2005). Its influence is so 
widespread that GFP has even been the subject of art: the German artist Julian Voss-
Andreae has created several sculptures based upon the structure of GFP (Voss-
Andreae, 2005). 
In this project GFP was used in an attempt to determine the subcellular localisation of 
HD-START domain proteins in hydra mutant backgrounds as compared to wild type 
Arabidopsis plants. The GFP used through the course of this dissertation was pMP N -
link GFP; a new experimental GFP construct created and kindly supplied by Dr 
Margaret Pullen. A map of the pMP-GFP construct may be viewed in appendix B. 
Since this GFP is experimental its use within this dissertation takes on a second 
purpose: to determine i f the pMP N-linkGFP functions correctly. 
1,3.1.2. The ale System 
In order to study gene activity in plants, several expression systems have been 
developed in which the external application of chemicals is used to induce 
transcription of the target gene (reviewed in Gatz, 1997; Jepson et a/., 1998, Zuo and 
Chua, 2000). This enables the studied genes to be 'switched on' transcriptionally at 
specific times during development. This method therefore permits the study of 
specific genes by effectively introducing them into an already functional and healthy 
system. 
Modified versions of these systems have already proven to be useful tools in the study 
of several other plant mutants. The external application of dexamethasone to a 
dexamethasone-inducible system has enabled the targets of both the AP ETA LAS and 
CONSTANS transcription factors to be identified, greatly furthering the understanding 
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of how they function (Sablowski and Meyerowitz, 1998; Samach etal., 2000) 
The ale expression system has been developed based upon a group of co-regulated 
genes which have been identified in Aspergillus nidulans and which use ethanol to 
control gene exression (Pateman ef a/., 1983; Sealy-Lewis and Lackington, 1984; Felenbok 
etal., 1988). In this naturally occurring system a transcriptional regulator named aleR 
will only induce expression of the genes in the ale regulon i f there is ethanol present 
(Caddick etal., 1998; Salter ef a/., 1998) 
For this dissertation a modified version of the ale system from A. nidulans was used 
in an attempt to determine the subcellular localisation of the different HD-START 
domain genes in both wild type Arabidopsis and hydra mutant backgrounds. A 
graphic depiction of the binary vector ale system and how HD-START domain genes 
were cloned into it is displayed as Figure 3. 
The system used here is a binary vector system. For this experiment the two vectors to 
be used are pACN (the smaller initial vector; 4024bp) and pSRNACNbin (the larger 
final vector; 16515bp). Maps of both of these vectors can be seen in appendix B. 
The desired outcome of the cloning procedures for the fluorescence microscopy is that 
each full length HD-START domain gene should be linked directly to pMP N-link 
GFP within the pSRNACNbin vector, and thence be able to be added to Arabidopsis 
plants both with and without a hydra background to act as a reporter for the genes' 
subcellular localisation. This outcome can be achieved in two different ways. The 
first, as intended, is the process which was used for Revoluta: pMP N-link GFP would 
be inserted into the pACN vector, Revoluta would then be inserted into pACN such 
that it became linked to the GFP. Then both the Revoluta and the GFP would be 
excised as a single fragment using Hind I I I , before being inserted into the Pst site of 
pSRNACNbin (as depicted in FigureS). However, both GL2 and PHB contain internal 
Hind III sites and therefore would be incapable of being excised from pACN as a 
single fragment. Consequently the process for GL2 and PHB cloning would be 
different: pMP N-link GFP would be inserted directly into pSRNACNbin at the 
SnaBl site, and the HD-START domain genes would have to be linked to it directly 
by addition straight into the larger vector. 
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531. 
pACN:GFP(M) 
H<rdlSL 
Figure 3: Diagrammatic representation of the way in 
whicli each of the three HD-START domain genes 
w a s to be cloned Into the alcohol inducible binary 
vector pSRNACNbin. 
(A) To the left: Revoluta. Previously cloned Into 
TOPO with BamHI linkers it must first be excised 
from TOPO using BamHI. Then H^ lung Bean SI 
Nuclease must be used to remove the overhang left 
over from the BamHI restriction. It should then be 
inserted into pACN:GFP(N)-the pACN vector 
containing pMP N-link GFP (see appendix B). The 
only SnaBI site in pACN:GFP(N) occurs in the pMP 
N-linked GFP in such a w a s that Revoluta would 
remain in frame were it to be inserted there. Once 
inserted into the smaller of the two alcohol inducible 
vectors restriction with Hindlll would excise both 
the ptvlP N-link GFP and Revoluta as a single in-
frame DNA fragment. This could then be inserted 
into the Pst site of pSRNACIMbin, creating the 
completed vector, 
(B) To the right: Glabra 2 and Phabulosa. These 
exist initially as cDNA to be amplified, and in this 
case they were amplified with linkers incorporating 
a SnaBI site. Once amplified they must be inserted 
into TOPO and verified, and may then be excised 
from TOPO. However, their sequences contain 
Hindlll restriction sites and as a result they cannot 
be inserted into pACN:GFP(N) in the same way that 
Revoluta can. Glabra 2 and Phabulosa would 
therefore have to be inserted directly into 
pSRNACNbin: GFP. 
- T C f O 
|)SRNACNI>iii:GFP pSRNACNbin 
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1.3.2. Real-time RT PGR 
When investigating the mRNA levels of different genes, or of a single gene against 
different mutant backgrounds, there are several different experimental methods 
available. As well as northern blotting and cDNA arrays (Butcher, 1999; Parker and 
Barnes, 1999) one can use the quantitative real-time Reverse Transcription 
Polymerase Chain Reaction (real-time RT-PCR). This method of PCR is one of the 
most sensitive methods for the detection and quantitation of mRNA, and would 
therefore be suitable for use with plant tissue samples of limited mass (Bustin, 2000) 
which is a problem the hydra mutants pose, being both diminutive in size and having 
a low germination frequency. 
Although real-time RT-PCR studies were used to quantify the HD-START domain 
mRNA levels by analysing the mRNA samples, mRNA itself cannot be used as a 
template for PCR reactions. Consequently all mRNA present must first be used to 
create cDNA replicas which may in turn act as a template for the PCR runs. The 
method by which this was carried out is detailed in section 2.2.1.4. 
For the real-time RT-PCR studies in this dissertation the data collection is 
flouorescence-based, utilising the fluorescent dye SYBR Green: a cyanine dye which 
absorbs blue light at A a^x 488nm and emits green light at X^zs 522 nm (Zipper ef a/. 
2004). When not bound to DNA, SYBR Green exhibits negligible fluorescence, 
however it binds indiscriminately to double-stranded DNA and, in doing so, 
fluoresces more strongly. Therefore the greater the quantity of double-stranded DNA 
which forms in the real-time RT-PCR reaction tubes, the greater the level of 
fluorescence will become (Morrison etal., 1998). This fluorescence may be detected 
and this way the level of fluorescence exhibited in any PCR reaction tube will act as a 
representation of the amount of amplified product. For the mRNA studies in this 
dissertation the BioGene real-time RT-PCR system was used. For each PCR run the 
level of fluorescence in every PCR tube was automatically measured by the BioGene 
machine during the 'extension' step of each of the cycles - the step in which the DNA 
was double-stranded (details of the PCR conditions used may be seen in section 
2.2.2.2). Transparant thin-walled reaction tubes enable both the addition of blue light 
and the recording of emitted fluorescence. 
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Due to the high sensitivity of real-time RT-PCR assays the conditions under which 
the PGR reactions themselves were carried out must be carefully chosen and strictly 
regulated. One such factor is the primer pair used to amplify the desired product. It is 
preferable to use primer pairs which amplify short sequences of the target gene 
(Bustin, 2002) however this is not the only aspect of the primers which requires 
attention. Primer dimmer formation is a subject of concern as it can prevent the 
completion of successful real-time RT-PCR assays. A number of computer programs 
are currently available to aid the selection of possible primer sites (Rychlik et al. 
1990). This experiment made use of the Oligo program (Molecular Biology Insights 
Inc.) to identify which sections of the HD-START domain genes being tested would 
be likely to contain functional and distinct primer sites, although the exact sequences 
of each primer used was determined manually. 
By using real-time RT-PCR and the other experiments described it is hoped that 
further evidence may be gathered to either strengthen or refute the hypotheses 
described in this introduction 
Part 2: Materials and Methods 
2. Materials and Methods 
2.1. Frequently Used solutions/methods 
2.1.1. LB (Lauria-BertanI) Medium 
The bacteria used in this project were grown in Lauria-Bertani medium, used both as 
a liquid (for plasmid preps) and, with the addition of agar, as a thick gel used when 
growing colonies. When making LB stock, each litre was made with distilled water to 
include: lOg of peptone (Duchefa Biochemie), 5g yeast extract (Duchefa Biochemie), and 
5g NaCl (Sigma). When dissolved, this liquid LB and is typically decanted into 5ml 
and 20ml aliquots. For LB agar, 15g of agar (typically bacto-agar or select agar) is 
added per litre of mix and decanted into 400ml portions prior to autoclaving. Some 
LB medium used during this project were selective, with antibiotics (such as 
kanamycin, used at 50|ig ml"', and carbenicillin, used at 100 ml"') and X-gal (used 
at 40^g ml'') being added when appropriate. 
2.1.2. Plant Growth Medium 
All plants studied in this project were initially grown in V2 MS 10 media. Plants are 
typically typically grown on a mix of salts first developed by Murashige and Skoog in 
1962, which are still known as MS salts (composition details are given in: Murashige 
and Skoog, 1962). Ordinarily growth media would contain 4.4g 1"' of MS salts, 
however for V2 MSjo only half the concentration of salts are used (2.2g I"') along with 
lOg of sucrose. For all media used throughout this dissertation the pH was adjusted to 
5.6/5.7 before the bactoagar was added at a concentration of 8g I"'. Out of preference 
phytoagar would have been used, however this can degrade Kanamycin, which was 
used during this experiment. 
2.1.3. TAE gel electrophoresis buffer 
This solution is used both to buffer the electrophoresis gel during the process, and to 
make the gel itself. The buffer (lOx) consists of the following components mixed in 
5L of distilled water: 242g Tris (Analar), 57.1ml glacial acetic acid (Fisher Chemicals), 
and 37.2g Na2EDTA.2H20 (Sigma), 
The gel on which DNA samples are run during electrophoresis is a 1% agarose gel, 
such that a 50ml gel would be made with 0.5g of agarose added to 50ml of Ix TAE. 
After being heated in a microwave until it was fiilly clear, and allowed to cool until it 
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was approximately 60°C, 2^1 of Ethidium Bromide was added. 
2.1.4. Agarose Gel Electrophoresis 
This is a DNA examination technique which enables fragments to be separated 
according to size. Once a gel - made as described above - sets, it is submerged into a 
tank of IxTAE Electrophoresis buffer. The DNA samples to be separated are placed 
in wells at one end of the gel so that they sit within the gel itself An electrical current 
is then passed through the gel with the negative electrode located next to the side of 
the gel with the DNA wells in and in parallel to them, and the positive electrode at the 
opposite end of the tank. Therefore the DNA, a negatively charged molecule, would 
move forwards through the gel itself; with smaller molecules moving more rapidly 
through the gel than larger molecules. The DNA is made visible under UV light by 
the incorporation into the gel of ethidium bromide, which binds to the DNA by 
slipping between adjacent base pairs (Southern, 1979; Sambrook and Russel, 2001). 
The first, and sometimes also the last, lanes were loaded with hyperladder I (Figure 4; 
Bioline) to allow the determination of both the size of the DNA molecules being 
examined and an approximation of the mass of DNA contained in each band. The 
actual samples were loaded with the following mix; 2 ^il of the DNA sample, 6 | i l 
distilled water (to add volume in order to facilitate pipetting) and 2 i^l of loading dye 
(where 10 ml contains 3ml glycerol and 25mg Bromophenol blue, made up to 10ml 
with distilled water).These samples were loaded into the wells of the submerged gel, 
and then run until about half way down the gel at between 68 V and 130V, depending 
upon the size of the gel. 
2.2. RNA extraction and analysis 
2.2.1. Preparation 
2.2.1.1. Growth Conditions for Plants 
All Arabidopsis seeds, except those cultivated during the dissertation itself, were 
kindly provided by Dr Topping. The seeds used were the standard Columbia (Col-0) 
ecotype (to be referred to as wild type), from plants heterozygous for the hydra 1-2 
mutation, and from plants heterozygous for the hydra 2 mutation. Al l seeds were 
10.000 
8.000 
6.000 
5.000 
4.000 
3.000 
2.500 
2.000 
1.500 
1.000 
Band Size (bp) DNA Per Band 
100 
8 0 
6 0 
50 
4 0 
30 
25 
20 
15 
100 
8 0 
6 0 
4 0 
2 0 
Figure 4 : Hyperladder I, 
from Bioline. This was 
used alongside samples 
generated during the 
experiment to determine 
DNA size in each gel 
electrophoresis test in this 
dissertation. 
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sterilised and grown in the plant medium described in section 2.1.2 and, as it aids the 
germination of those seedlings homozygous for either hydra mutation, all were kept 
away from light and maintained at 4°C for two weeks prior to their removal to the 
plant tissue culture facility. In this facility plants were kept under light for 24 hours a 
day. Growing seedlings remained in the plant tissue culture facility for five or six 
days before being transferred to greenhouses, although all seedlings to be used 
specifically for RNA analysis remained in the facility indefinitely. 
Although theoretically the heterozygotic seeds should result in one in four progeny 
being homozygous for hydra and therefore showing hydra phenotype, this was not the 
reality. The germination frequency for hydra mutants is much larger than would be 
expected by simple probability, especially for the hydra 1-2 mutants. Therefore 
experiments requiring the use of homozygous hydra mutants had three times as much 
plant tissue with which to work for hydra 2 studies than hydra 1-2 studies. 
2.2.1.2. RNA Extraction 
Seedlings were sampled at days 9, 11, and 13 of development. It had been hoped a 
longer time frame could be tested, however before day 9 the hydra mutants were too 
small to sample, and after day 13 many began to die. Therefore for each sample point 
60mg to 90mg of plant material was weighed out in sterile eppendorphs, frozen 
immediately in liquid nitrogen and stored at -80°C until needed (after approximately 
two weeks). Samples were kept frozen in liquid nitrogen as they were ground into a 
powder using a mini pestle in an eppendorph, with approximately 10|il of sand being 
used to aid tissue grinding (this was necessary due to how tough the tissue of hydra 
seedlings is). RLT buffer (containing lOjxl mf ' Beta-mercaptoethanol; Beta-ME) was 
added to prevent degradation of the mRNA as the tissue thawed, and the sample was 
spun down in a microcentrifuge for 30 seconds in order for the sand to separate from 
the sample and form a pellet. The supernatant was then removed carefully with a 
pipette and added to a spin column. Thereafter the rest of the RNA extraction 
followed the method set out in the Qiagen RNeasy RNA minipreps kit (the details of 
which are listed fully in appendix C) from step 3 onwards. Also, in order to remove 
any possible contaminating DNA all samples were given a DNase treatrt^ent. For this 
treatment the RNeasy plant mini protocol was used (see appendix C). 
2.2.1.3. cDNA Synthesis 
In order to obtain a cDNA 'copy' of the extracted RNA samples the actual quantity of 
RNA in the purified sample was determined using a spectrophotometer. Each 
individual sample had its A260 and A280 measured to enable the RNA concentration to 
be determined by the following formula: 
[RNA] = 40 X A260 X 20 
Where 20 is the dilution factor (all tested samples were diluted in sterilised distilled 
water so that minimum RNA was lost for this particular calculation), and 40 is used 
because - for RNA - A260 is equal to 1 when the sample is at a concentration of 40 |J.g 
ml"'. Samples may be considered pure i f their A260 value divided by their A280 value 
falls between 1.8 and 2, therefore any samples which fell outside this range were 
discarded. 
Having determined the samples' concentration, cDNA synthesis could proceed. For 
each sample lOfxl total RNA (at lOOng |j,r') was mixed with 2^1 oligo(dT) primers, 
spun briefly in a microcentrifuge, and heated for 3 minutes at 70-85°C. They were 
then removed to ice, spun briefly, and replaced on ice before the following 
components were added: 2|il RT buffer (RetroScript), 4^1 dNTP mix, 1^ 1 RNase 
inhibitor (RetroScript) and I|a.l MMLV-RT (Promega) as the reverse transcriptase. 
Samples were mixed gently, spun briefly in a microcentrifuge, then incubated at 50°C 
for 1 hour. They were then incubated at 92 °C for 10 minutes to inactivate the reverse 
transcriptase, and stored at -20 °C until required. 
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2.2.2. Analysis 
2.2.2.1. Primers 
Quantitative real time RT-PCR was used to investigate the expression of START 
domain transcription factors, and oligonucleotide primers were designed for each of 
these genes. Each of the primers was assigned a 'name' according to the following 
rules; rtRT-PCR (to indicate the experiment the primers were created for), the name 
of the gene (e.g. REV for REVOLUTA), then whether the direction of the primer is 
forward or reverse. These primers are detailed in Table 1. 
Primer Name Sequence (3' to 5) 
Size of Product 
Created from 
cDNAgDNA 
rtRT-PCR_AtML1(for) 
rtRT-PCR_AtML1(rev) 
CCCTCAGCTCTCTTCTTCACACCA 
TGATACAATCCCGCAGAACACACT 
438bp / 530bp 
rtRT-PCR_GL2(for) 
rtRT-PCR_GL2(rev) 
GAAGTCCCGTATTGCCGAGATTT 
T C C ACTATTGC C C A T I T C T C A G G 
461bp/645bp 
rtRT-PCR_PHB(for) 
rtRT-PCR_PHB(rev) 
GCAGCAGCTCGTGACTnTGGAC 
CTCTGCACCATCGCTACCCATTG 
473bp / 803bp 
rtRT-PCR_PHV(for) 
rtRT-PCR_PHV(rev) 
CGTCCTTGTGATGGTGGTGGTrC 
ATAGAAGCTnGGCACAGAGGAC 
421bp/643bp 
rtRT-PCR REV(for) 
rtRT-PCR REV(for) 
C AATG CTTCTC C AAAATGTTC CT 
TGTACATCTCCCGI 1 1 lAGCATC 425bp / 723bp 
Table 1: Primers used for real-time RT-PCR studies. The table shows the 
sequences of the forward and reverse primers for each of the five START domain 
genes. The size of the products each primer pair would create is listed both for 
cDNA and for gDNA. This allows for the distinction of the desired cDNA from any 
contaminating genomic DNA (which contains introns and would therefore result in a 
larger product.) thereby enabling the purity of cDNA samples to be assessed. 
2.2.2.2. Real-Time RT-PCR 
Some of the factors which must be taken into consideration when designing real-time 
RT-PCR primers were mentioned in section 1.3.2. However, as well as the makeup of 
the primers themselves the concentration at which they are used in the reaction mix 
requires consideration. Indeed, due to the sensitivity of the real-time RT-PCR assays 
the optimal concentration of each component in the PCR master mix should be 
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determined to ensure accuracy of results. Prior to any reactions being carried out on 
the BioGene real-time RT-PCR machine optimisation runs were performed on 
standard PCR machines. For each of the five genes to be tested and the positive 
control gene ACT2 (strongly expressed in all cells) sets of PCR reactions were carried 
out to determine the optimal concentration for every one of the components included 
in the PCR mix (by studying the gel electrophoresis results for each optimisation run). 
The final chosen volumes of PCR reactants for the real-time RT-PCR studies are 
listed in Table 2. Where possible it was decided that genes which were shown to 
provide clear results (bright and well defined bands on the electrophoresis gels 
produced during optimisation) for the same or very similar concentrations of 
reactants, would use the same PCR conditions. 
PCR Reaction M l \ 
Component 
Volume 
ACT2/AtML1/ 
GL2 /PHB/PHV 
R E V 
xlO Buffer (without MgC^) 2.0til 2. Old 
dNTPs (lOmM) 0.6tU 0.6nJ 
Forward primer (20pM) 0.2ni 0.2til 
Reverse primer (20pM) 0.2[il 0.2id 
cDNA(10ng m1-1) 0.4mI 0.4pl 
MgCl2 (50mM) 0.6iii 0.4mI 
Sterile Water 15.5tU 15.7nJ 
SYBR Green 0.3iil 0.3til 
Taq PoljTiierase 0.2[il 0.2tLl 
Table 2: Table showing the volumes of P C R 
reactants used in the real-time R T - P C R studies. 
As well as the Taq polymerase, the SYBR Green fluorescent dye was added and 
mixed moments before the reaction tubes were placed into the BioGene real-time RT-
PCR machine. Both Taq and SYBR Green require storage at -20°C, therefore being 
exposed to room temperatures for any length of time before the PCR run started could 
only weaken their performance. SYBR Green must also be stored in complete 
darkness to prevent the fluorescence from becoming inactive, therefore it was the 
final PCR component added (to ensure the reaction tubes containing SYBR Green 
spent as little time as possible in the light). 
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The PGR machine was run according to the following requirements, determined by 
initial experimentation using standard PGR machines: After initially heating the 
sample at 94°C for 10 minutes a cycle was followed which consisted of denaturation 
for 30 seconds at 94 °C, annealing for 40 seconds at 58 °C, and extension for 60 
seconds at 72 °C. This cycle was repeated 60 times before the final extension phase 
took place, in which the sample was maintained at 72 °C for 10 minutes. 
2.3. Creation of START::GFP Fusion Vectors 
2.3.1. Cloning 
2.3.1.1. Amplifying the genes 
The REV, PHB and GL2 genes weresupplied as cDNAs by Dr Topping (at lOng ^1"'). 
The full length Revoluta {REV) gene had previously been cloned into the TOPO 
vector in E. coli cells (strain JM109). The Revoluta-coniammg TOPO plasmid was 
sent for sequencing with the internal primers marked in the appendices. The sequence 
returned showed an open reading frame throughout, and displayed almost complete 
homology with the published sequence being used, and where any difference occurred 
it was consistent with a second published sequence (the 'table' for how the sequence 
lines up with both these published sequences may be seen in appendix C). The 
Revoluta cloning description from this point on shall be covered in section 2.3.2. 
For each of the remaining genes, Phabulosa and Glabra 2, PGR was used to amplify 
the original template for use during the project. The primers used have been designed 
to amplify the genes with linkers to facilitate cloning into the GFP fusion vector, and 
restriction sites were incorporated into each primer at the 5' end to allow the 
amplified gene to be cloned into the vector. 
Primers used for the reaction 
Each of the primers was assigned a 'name' according to the following rules; FL (for 
amplifying the full-length gene as opposed to just the start domain), then the name of 
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the gene (e.g. GL2 for GLABRA 2), pMPN-linkGFP (since the primer is designed to 
facilitate cloning into the pACN:GFP(N) construct) then whether the direction of the 
primer is forward or reverse, before finally stating which restriction enzyme has been 
added (in each primer here Sma I was used). These primers are listed in Table 3. 
Primer Name Sequence p'to 51 
FL-GL2_pMPN-lmkGFP^or) 
FL-GL2_pMPN-linkGFP(rev) 
TGCCCGGGATGTCAATGGCCGTCGACATGTCTTCCA 
CCXX'GGGCGCATGCAGCAATCITCGATITCjrAGACTrCTC 
FL-PHB_pMPN-lmkGFP(for) 
FL-PHB_pMPN-linkGFP(rev) 
GC'CCGGGATGATGATGGTCCATTCGATGAGCAGAG 
GCCCGGGTCAAAGCAACGACCAATTCACGAACA 
Table 3: Primers used for amplifying the PHB and GL2 genes for full length 
cloning into the alcohol inducible vector. The table shows the sequences of the 
forward and reverse primers for each gene, with the Sma I restriction sites 
highlighted in blue. 
PGR Protocol 
The PGR protocol for amplifying the full length genes, including the restriction sites 
by which they are flanked, utilised the Expand High Fidelity PGR System (Roche see 
appendix C). The proofreading 3' to 5' exonuclease activity of the Expand enzyme 
ensures a higher degree of accuracy then many other enzymes (such as Taq 
polymerase), and therefore generates fewer errors during the reaction. The PGR 
solution used in each of the reactions can be seen in Table 4. 
PCR Reaction Mix 
Component Vohime 
xlO Bufifer (wilhout MgCy 5vl 
dNTPs (lOmM) 1.5nJ 
Forward primer (20pM) \.5\d 
Reverse primer (20pM) \.5\il 
cDNA(lOngiil-l) 
l!4lgCl2 (25mM) 
Sterile Water 
Expand &izyme 0.5\d 
From Table 4 it is evident that the 
PCR solution would therefore have 
a final volume of SOpJ, with the 
addition of 0.5^1 of the Expand 
enzyme only after the rest of the 
PGR mix had been heated to 94°G 
in the PGR machine. This 'hot 
start' is required because the 
polymerase activity of Expand 
only occurs at this elevated 
temperature, whereas the 
proofreading function may occur across a much wider range, therefore adding Expand 
Tab le 4: The PCR solutions used when 
amplifying the full length Phabuhsa and 
Glabra 2 qenes. 
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before the solution is heated would lead to denaturation o f the DNA. 
The PGR machine was run according to the following protocol: After initially heating 
the sample at 94°C for 10 minutes a cycle was followed which consisted o f 
denaturation for 1 minute at 94 °C, annealing for 2 minutes at 55 °C, and extension for 
5 minutes at 72 °C. This cycle was repeated 30 times before the final extension phase 
took place, in which the sample was maintained at 72 °C for 10 minutes. 5)il o f the 
enzyme Taq polymerase was added to the solution for this final extension phase in 
order to add an A-overhang onto the DNA to facilitate cloning into the TOPO vector. 
2.3.1.2. Cloning into TOPO vector 
The TOPO vector (pCR®II-TOPO®, Invitrogen ; shown in appendix B) is provided in a 
linearised form, with the enzyme D N A Topoisomerase I covalently bound, facilitating 
the ligation o f complementary overhanging sequences. The linearised vector has a T-
overhang which directly complements the A-overhang o f the PGR products. 
For each of GL2 and PHB the fol lowing mix was made: 0.5^1 o f PGR product was 
added to 3.5 | i l sterile water 1^ 1 MgG12, and 1 ^1 TOPO cloning vector. This solution 
was left to incubate at room temperature for 30 minutes, before being returned to ice. 
Transformation o f chemically competent E.coli cells (strain JM109, in tubes o f 
approximately 300|il) began as 2|al o f the cloning mix was added to a phial o f cells, 
and the contents mixed gently. The cells were then incubated on ice for 30 minutes 
before being heat shocked at 42°G for 30 seconds and then returned to ice, at which 
point 250^1 of liquid LB was added. The cells were then left to incubate for an hour at 
37°C on a horizontal shaker before being spread onto plates containing kanamycin (to 
ensure only bacteria containing the TOPO plasmid would survive) and X-gal (to allow 
positive identification o f cells which contained the START domain gene insert: 
colonies which would be white in colour as opposed to blue). Plates were then left 
overnight at 37°C to allow colonies to form. 
2.3.1.3. Colony PCR 
The following morning, after plates o f transformed cells were left to incubate, 
colonies were tested to determine i f they had taken up the gene of interest. Golony 
PGR was carried out on a sample o f 20 colonies which appeared white or pale blue. 
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with a dark blue colony used as a negative control. The primers used for these colony 
PCR tests were those created for the real-time RT-PCR tests and are listed in Table 1. 
This and subsequent PCR tests were carried out using Taq polymerase (Promega) 
since a proofreading enzyme was not required. 
Once these cycles had finished, 2|xl o f loading dye was added to each tube and the 
samples were loaded onto an agarose gel to undergo electrophoresis. Once this 
process was completed, five o f the colonies (for each gene) identified as containing 
the correct insert were chosen to be grown in an overnight culture. Each was added to 
5ml o f LB medium containing 5|il o f xlOOO kanamycin stock. A flame-sterilised loop 
was used to l i f t bacteria from the colony into the culture medium, and the bacteria 
were then incubated overnight at 37°C on a shaker. 
2.3.1.4. Plasmid Preps of Transformed Cells 
In order to isolate the plasmids from the transformed bacteria, the Wizard® Plus D N A 
Purification System was used (Promega - see appendix C). 
For each colony tested 1 ml of overnight culture was placed in each o f 4 eppendorphs, 
such that 4ml o f culture was used per colony. The tubes were centrifuged at fu l l 
power for 5 minutes so that a pellet formed. The supernatant was emptied and 
disposed of, and the pellet was tapped dry as much as possible. 
To the first o f the four eppendorph tubes (for a given colony's culture) was added 
250^1 o f resuspension solution, it was then mixed thoroughly so that the pellet was 
completely resuspended. The mix from the first eppendorph was then added to the 
second, third, and final eppendorphs, with this resuspension being repeated such that 
the fourth tube contained 250|j,l resuspension solution along with the contents o f the 
pellet from each eppendorph. 
250^1 lysis solution was then added to the mixture to break the cells open, the tube 
was inverted four times to mix. Then 10^1 alkaline protease solution was added to 
break down cellular proteins, the mix was inverted four times before being left to 
incubate for 5 minutes. At the end o f this incubation, 350)4,1 o f neutralisation solution 
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was added and the tube was inverted four times. 
The solution was then centrifuged on fu l l power for 10 minutes. The supernatant was 
then removed, without disturbing the pellet, and transferred to a spin column within a 
catch tube. This tube was then placed in a centrifuge on fu l l power for 2 minutes, after 
which the flow-through was discarded. Into the spin column was then added 750|il 
column wash solution, before being centrifuged on fu l l power for 1 minute. The f low-
through was again discarded, and the wash repeated with 250^1 column wash 
solution. Having emptied the through-flow, the tube was centrifuged whilst dry for 2 
minutes. 
For the final step, 50^1 nuclease-free water was added to the spin column which was 
then centrifuged on fu l l power for 1 minute. The through-flow from this step is the 
plasmid itself, so it was stored at -20''C. 
2.3.2. Cloning of HD-START domain genes into the binary vector 
The REVOLUTA gene, as previously stated, had been amplified using the Expand 
High Fidelity PCR System - and found to have no amplification errors at an earlier 
date. It was, however, amplified with BamHl linkers. Before cloning could proceed 
further REVOLUTA needed to be excised f rom the TOPO plasmid and have the Bam 
H I linkers removed. To remove REVOLUTA the TOPO plasmid was digested with 
Bam H I as follows: 1^ 1 o f lOx buffer (for use with Bam H I ) was mixed with 2 n l 
sterile water, 6t ^1 TOPO plasmid, and 1 |j.l Bam H I . This mixture was maintained at 
37°C in a water bath for 2 hours. 
Mung Bean SI Nuclease (Promega) was then used to remove the overhanging D N A 
ends. The procedure used was essentially the same as for the Bam H I digest but 
tailored for Mung Bean SI Nuclease. A l l digests used through this experiment were 
performed in the same way, wi th buffer and incubation temperature being altered to 
the enzyme used. Shrimp Dephosphorylase (Promega) was then used to treat the blunt 
ended D N A in order to facilitate ligation into the next vector, pACN. Since pMP N -
link GFP had been inserted into pACN to form pACN:GFP(N) the next step was to 
link REVOLUTA with pMP N-l ink GFP by inserting it into pACN at the SnaBl site. 
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This is a blunt-ended ligation, and the intention was then to excise the REV::pMP N -
link GFP fusion with Hind I I I in order to transfer it to pSRNACNbin. However, as 
shall be discussed in section 3.2., this objective proved unobtainable. 
As shown previously (in Figure 3) both Glabra 2 and Phabulosa contain internal 
Hind I I I sites which prevent them passing through the first stage o f the binary vector 
system. It is for that reason that both genes need to be cloned directly into 
pSRNACNbin containing pMP N-tail GFP (pAIbinNGFP). Both o f these genes were 
amplified with Sma I linkers, and both were added to pAIbinNGF at the Sna B l site. 
This, as with REVOLUTA, is also a blunt-ended ligation. 
For both o f these blunt-ended ligations the enzyme T4DNA polymerase was used. 
This enzyme works at room temperature but works slowly. Therefore when cloning 
attempts were made the eppendorphs were left at room temperature on the bench 
overnight. As shall be described in section 3.2., these cloning reactions proved 
problematic, and were repeated often. In an attempt to increase vector take-up the 
vector mass:insert mass ratio was altered many times, ranging from 1:1 to 1:10. 
When moving the DNA between vectors during this dissertation genes and constructs 
have, at times, needed to be excised from vectors and then isolated. In these situations 
the Roche High Pure® Purification kit for the purification o f D N A from an 
electrophoresis gel was used. 
2.3.3. DNA sequencing 
A l l sequencing in this dissertation was carried out in the University o f Durham D N A 
Sequencing Facility, using the A B I Prism 377 D N A sequencer. 
30 
2.4. Plant Preparation and Microscopy 
2.4.1. Transformation and Growth of Agrobacterium 
The method used in this project to transfer the desired vectors into Agrobaclerium 
tumefaciens (strain C58C3) has been altered f rom that first described by Bechtold et 
a.l (Bechtold ef a/.,1993). Cultures of Agrobaclerium were grown in 200ml L B , in 
which their initial stage o f growth occurred, and the medium contained nalidixic acid 
(at a concentrafion o f 25mg 1"'), streptomycin (at a concentration o f lOOmg ml"'), and 
kanamycin (at a concentration o f 50mg 1''). Cultures were maintained at 30°C for 
between 40 and 48 hours whilst being shaken. 
After two days o f incubation at 30°C each culture tube was spun down in a cooled 
centrifuge until it formed a pellet. The supernatant was decanted and the pellet was 
resuspended in a I litre solution o f sterile distilled water with a concentration o f 5% 
sucrose, to which Silwett L-77 (Lehle Seeds) was added to a final concentration o f 
0.05%. This solution, once made, is ready for dipping instantly and cannot be kept. 
2.2.2.1. Transformation of Plants 
Young siliques and open flowers were trimmed f rom three week old Arabidopsis 
plants two days before dipping was due to take place (at roughly the same time as the 
initial Agrobacterium cultures were left at 30°C. These plants had been kept in a 
controlled Arabidopsis growth room (with warmer and more humid conditions than 
conventional greenhouses) during their development to ensure that no thick cuticles 
had formed and therefore dipping would be more likely to be successful. Each plant 
was dipped down into the Agrobacterium solution for approximately 20 seconds 
before being removed and placed away from the light in transparent platic bags (in 
order to create a humid environment for the Agrobacterium) overnight. The fol lowing 
morning plants were moved back into standard greenhouse conditions before the 
dipping process was repeated 7 days later. Thereafter the plants were kept 
permanently in standard greenhouse conditions and set seed. To facilitate seed 
collection the plants were placed in large transparent bags, also preventing cross 
contamination between other plants. Once the Arabidopsis plants had dried and turned 
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white in colour the seeds were harvested and left to dry for three weeks at 25°G. 
2.2.2.1. Selection 
When dry the seeds were sterilized and sown onto selective '/z MSio media. The media 
contained kanamycin at a concentration o f 35mg 1"', to allow for selection for 
transformed plants, and vanomycin at 850mg P' to stop the growth o f Agrobacterium 
on the plant growth medium, which could quickly grow and overwhelm the seedlings. 
Those plants which survived the kanamycin selection and remained looking healthy 
were later planted up into growth pots in the greenhouse, and as they became mature 
and formed seed the siliques were opened and studied under a microscope. Those 
plants found to have homozygous hydra mutants amongst their progeny were noted, 
and those which appeared only to have wi ld type progeny were discarded as they were 
of no further use in this study. 
2.2.2.1. Induction 
Ethanol induction o f chosen plants was carried out in three ways to see which 
obtained the better results. A l l plants were sealed in 31 containers. Some of the plants 
were induced by root drenching with 0.3% ethanol, however these showed no signs 
of fluorescence when examined by confocal laser scanning microscopy. Those plants 
which were treated by ethanol vapour, where a beaker containing 100ml o f 70% 
ethanol was placed in the 31 container with them, all wilted within hours most died. 
Therefore induction by ethanol vapour did not prove to be effective in this case. 
The method which was consequently used for all plants tested in this experiment was 
the induction o f GFP expression by ethanol spray. A 0.5% ethanol spray was used 
until the solution began to run o f f the leaves, and tissue was then sampled at 3 hours, 
6 hours, and 18 hours after induction. Samples were immediately taken to the 
microscopy room for confocal laser scanning microscopy studies and images were 
taken. 
Part 3: Results 
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3. Results 
3.1. Quantitation ofRNA Levels by Real Time RT-PCR 
The aim of the work described in this section was to determine whether the mRNA 
levels of START domain transcription factors, which variously regulate vascular 
tissue and leaf dorsiventral pattern, which are defective in the hydra mutants, is 
altered in these mutants. As described in sections 1.1.5 and 2.2, the quantitation of 
mRNA levels in Arabidopsis seedlings was tested across several different factors. 
Trends across time, individual START domain genes, and type of seedling (wild type, 
hydra 2, and hydra 1-2) would be too complex to discuss at once, so results obtained 
for each gene shall be examined before more general trends are addressed. There is, 
however, one important point of information which is required to understand more 
fully the forthcoming results: real time reverse-transcriptase PGR is a tool being used 
here to measure cDNA created from mRNA, so the levels detected and described here 
directly represent those of DNA transcribed into mRNA. A number of factors could 
affect what proportion of the mRNA was translated into protein, and the activity of 
any protein produced. It is for this reason that the mRNA levels (steady state 
transcription levels) described below represent only one facet of gene expression. 
ATMLl 
When both the hydra 2 and the hydra 1-2 samples were tested with the primers for 
isolating AtMLl (as described for all genes in section 2.2), the steady state 
transcription level of AtMLl was shown to decrease with time with respect to the wald 
type steady state transcription level (see Figure 5A). The steady state transcription 
levels in the hydra 1-2 mutants declined from an initial high of 30% above wild type 
steady state transcription (at day 9 of development) to 13% below wild type at day 13. 
Therefore, through a developmental period spaiming five days, the AtMLl gene 
dropped from being clearly upregulated to downregulated as compared with wild type 
seedlings. 
The most significant result for AtMLl was however seen in the hydra 2 mutants. In 
these the steady state transcription levels were found to be consistently below those 
shown in the wild type. At 9 days this apparent downregulation was at 19% below 
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Figure 5: Level of mRNA present in hydra mutants compared to wild type plants. 
Developing plants were sampled aged 9, 11, and 13 days. Tissue was taken for each in 
the form of whole seedlings, and the level of mRNA was tested for specifically by real-
time RT-PCR. Each data point for hydra 2 represents the mean of 12 samples, for hydra 
1-2 it represents 4 samples. This figure shows data for the mRNA of; A| A t M L I , 
PHB, Q GL2, D| PHV, E) REV, and F| ACT2. 
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Figure 5: Level of mRNA present in hydra mutants compared to wild type plants. 
Developing plants were sampled aged 9 , 1 1 , and 13 days. Tissue was taken for each in 
the form of whole seedlings, and the level of mRNA was tested for specifically by real-
time RT-PCR. Each data point for hydra 2 represents the mean of 12 samples, for hydra 
1-2 it represents 4 samples. This figure shows data for the mRNA of; A| A t M L I , B\ 
PHB, Q GL2. D) PHV, E) REV, and FJ ACT2. 
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wild type, however by day 13 this had fallen considerably to 72% below the wi ld 
type, meaning that steady state transcription levels were only a quarter o f the value 
they would have been in a wi ld type Arabidopsis seedling. This downregulation 
clearly falls outside the standard deviation observed during the real time RT-PCR runs 
carried out for this experiment. 
PHB 
The pattern described above o f the steady state transcription level in hydra mutants as 
compared with wi ld type over time, which was observed when studying AtMLI, was 
very similar to that which emerged when samples were tested with the PHB primers: 
the steady state transcription levels all decrease with respect to wi ld type over time. 
The hydra 2 mutants show an initial upregulation o f almost 40% compared to the wi ld 
type seedlings at day 9, but fall steadily (although more data points at intermediate 
times would be needed to prove this conclusively) until the final sample - at day 13 -
was found to have 22% less PHB mRNA than the wi ld type. This matches quite 
closely with the actual numerical results o f the AtMLI steady state transcription in 
hydra 1-2 mutants. 
The most dramatic result o f all those obtained for the START domain genes tested in 
this experiment was that o f the level o f steady state transcription o f PHB in hydra 1-2 
mutants. At day 9 the level o f mRNA in the hydra 1-2 mutant seedlings was 359% 
that o f the wi ld type plants, a 259% upregulation. This is clear evidence that PHB is 
upredulated during hydra 1-2 development. Figure 5B also shows that this 
upregulation does not occur indefinitely: as with hydra 2 by day 13 o f development 
PHB mRNA levels may actually be downregulated compared to the wi ld type, 
however only by 14%. 
GL2 
Transcriptional analysis o f the GL2 gene produced a different pattern o f results. In the 
hydra 2 mutants the steady state transcription levels for GL2 on days 9 and 11 were 
essentially the same as in wi ld type seedlings - with only 6% and 2% lower RNA 
levels measured with respect to the wi ld type, and falling well within the standard 
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variation exhibited in wild type seedlings (see Figure 5C). The only result which 
seemed indicative o f abnormal gene mRNA levels was obtained for day 13, at which 
time steady state transcription was measured to be 14% lower than in wi ld type 
seedlings, though this value in itself was not significantly outside the standard range 
of error. 
This pattern o f almost constant steady state transcription levels with respect to the 
wi ld type through days 9 and 11, followed by a much larger drop in comparative 
steady state transcription was also evident in the hydra 1-2 mutants. For these plants 
the pattern was exaggerated: the earlier stages (days 9 and 11) were upregulated, 
unlike in hydra 2, with 24% and 35% respectively greater steady state transcription 
than the wi ld type. However, by day 13 the steady state transcription level had fallen 
significantly with respect to the wi ld type, f rom 135% of the w i ld type mRNA levels 
to just 75%. 
PHV 
Perhaps the most intriguing result was obtained for the PHV gene. Instead o f a general 
decrease o f steady state transcription levels with respect to the wi ld type over time (as 
exhibited with each o f the genes described so far) both the hydra 2 and the hydra 1-2 
mutants showed a significant peak at day 11. 
The steady state transcription level o f PHV in hydra 2 mutants at day 9 o f 
development was essentially indistinguishable from that o f wi ld type seedlings, 
whereas hydra 1-2 mutants had 26% less PHV mRNA present than in the w i ld type. 
Two days later the mRNA levels o f the hydra 2 and hydra 1-2 mutants with respect to 
wi ld type seedlings had drastically increased to 74% and 170% above the wi ld type 
value respectively. These are some of the most convincing results obtained in this 
experiment, falling clearly outside the standard deviation exhibited by wi ld type 
seedlings (see Figure 5D). However, as wi th AtMLl, PHB, and GL2 the results for 
day 13 o f development indicate that the steady state transcription level with respect to 
the wi ld type seedlings again starts to fa l l , although it does not fall back to wi ld type 
levels in either o f the hydra mutants. 
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REV 
Another unusual result came f rom testing for levels o f REVOLUTA mRNA over time, 
providing the only result for which the steady state transcription level appeared to 
increase towards day 13 o f development with respect to wi ld type over time (see 
Figure 5E). 
The hydra 2 and hydra 1-2 mutants remained consistently at or above the level o f 
revoluta mRNA found in wi ld type seedlings. That is not, however, to say that their 
value with respect to the wi ld type remained constant. Both mutants exhibited a fall in 
comparative steady state transcription levels between days 9 and 11 o f development, 
although this fall was more significant in hydra 1-2 (from a 44% upregulation to a 
32% upregulation) than in hydra 2 (which fel l f rom 12% upregulation to 6%; a small 
difference made even less notable by the error bars for these results, which show a 
large variability in the data concerned). Again the apparent increase in mRNA levels 
comparative to the wi ld type seedlings - which occurred between days 11 and 13 -
was greater for the for the hydra 1-2 mutants (increasing f rom 32% to 54% 
upregulation) than the hydra 2 mutants, where the rise was comparatively small. 
ACT2 
As mentioned previously ACT2, a housekeeping gene, was used in this experiment as 
a positive control. The ACT2 mRNA levels were measured in exactly the same 
manner as those HD-START domain genes discussed above in order to provide a 
'standard' to which they may be compared. 
The steady state transcription levels of ACT2 were observed to differ far less f rom the 
levels found in wi ld type seedlings than any o f the HD-START domain genes were. 
Five o f the six data points shown in Figure 5F fell within the standard deviation 
exhibited by wi ld type seedlings (indicated by the dotted grey lines). The levels of 
mRNA in the hydra 1-2 seedlings were again generally slightly greater with respect to 
the wi ld type seedlings than the hydra 2 seedlings, but with all six data points falling 
between 3% below and 9% above wi ld type levels. 
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OVERALL TRENDS 
Upon examining the data collected through real time reverse-transcriptase PCR (as 
described in section 2.2) some overall trends become apparent with regard to the 
hydra mutants themselves 
The most noticeable and consistent result to emerge is that the pattern of upregulation 
and downregulation of START domain genes - as compared with levels measured in 
wild type seedlings - is the same across both hydra 2 and hydra 1-2 mutants for each 
of the genes tested. This is largely to be expected considering the relative positions of 
the hydra 2 and hydra 1-2 
mutations in the sterol 
biosynthetic pathway (as 
described in section 1.1.1.3). 
However, what was 
unexpected was the difference 
observed between the results 
for the hydra 2 and hydra 1-2 
mutants with each gene tested. 
Table 5 is a table showing, for 
ease of reference, the greatest 
and lowest level of mRNA as a 
percentage of the wild type for 
both of the hydra mutants with 
each of the genes tested. From 
this table it is evident that 
mRNA. Level (as a % above or 
below Oe WOA. Tjpe) 
Gene Mutant ffighest Level Lowest Level 
A f l f l L l 
»fdra 1-2 
Hpdra2 
+29 -13 
-11 -72 
ca^ f^tta 1-2 
Hfdra2 
+35 -25 
-2 -14 
PHB 
Ffydbra 1-2 
Hftta2 
+259 -14 
+38 -22 
PHV 
Ifydra 1-2 
Hfdra2 
+170 -26 
+174 2 
REV 
ffydra 1-2 
Hydra 2 
•t54 +32 
+17 -»€ 
Tab le 5: Table showing the greatest arid 
least level of mRNA (as a percentage above or 
below the wild type) for each of the five START 
domain genes tested by real-time RT-PCR. Data 
for the hf/dra 1-2 and hydra 2 mutants has been 
separated in order to highlight their differences. 
For each gene the values for the hydra mutant 
which displayed the greatest range of results 
have been highlighted in bold. 
whereas both hydra mutants follow the same pattern of upregulation and 
downregulation through time for each gene tested, the hydra 1-2 mutant plants are 
displaying a more exaggerated version of the patterns observed in the hydra 2 
mutants. The only gene for which this was not the case was AtMLI. 
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3.2. Creation of STARTr.GFP Constructs 
3.2.1. Cloning of START: :GFP Fusion into ale System Vectors 
The aim of this part o f the project was to construct translational fusions between 
START domain proteins and GFP, for future localization studies in wild-type and 
sterol mutant plants. The cloning o f REV, PHB, and GL2 was carried out exactly as 
detailed in section 2.3. Revoluta was successftilly cloned into TOPO with the linkers 
ready for insertion into the p A C N vector containing the pMP N-l ink GFP. Phabulosa 
and Glabra 2 were successfully cloned into TOPO with the linkers which would be 
required for their insertion into the pAIbin GFP binary vector (since, as stated in 
section 1.2.1.3, their internal Hind I I I sites precluded them from first being cloned 
into the pACN vector). 
However, cloning was unable to progress successfully beyond this stage. Repeated 
attempts were made throughout the year; however in each case those vectors which 
had taken up the insert had done so in the incorrect orientation, ft was also noted that 
the colonies were very slow-growing - requiring at least two fu l l days at 37°C to 
reach the size ordinarily expected from overnight incubation at the same temperature. 
- and initially few colonies formed on each plate (typically about six were present). In 
order to increase the number o f colonies per plate in subsequent cloning attempts 
700|il o f culture were spun down, the majority o f the supernatant was removed, and 
the cells were resuspended in 150^1 of LB medium. This enabled more colonies to be 
tested per plate but was to no avail: GL2 and PHB cloning failed (due to being in the 
incorrect orientation) 243 and 251 times respectively, and REV^diS cloned backwards 
a total o f 312 times. During the course o f the year the experimental procedure was 
varied to ensure that it had no impact upon the cloning outcome, this included 
changing the E. coli cells used; using, amongst others, DH5a, TOP 10, TOPl -F ' (with 
IPTG), and X L Blue cells. 
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3.3. Microscopy 
3.3.1. START: :GFP Fusions and Fluorescence Microscopy 
Since the START::GFP fusions could not be created, Arabidopsis plants containing 
these genes evidently could not be tested. Therefore the subcellular localisation of 
START domain proteins could not be examined using confocal scanning fluorescence 
microscopy. However, since the GFP due to be used in this experiment (pMP N-link 
GFP, described in section 1.2.1) is a new, experimental form, this opportunity was 
used to test the functionality of the GFP construct itself: essentially running the 
experiment purely to observe the positive control. Having transformed Arabidopsis 
pants using the pSRNACbin vector containing only the pMP GFP construction (i.e. 
pAlbin GFP), the remainder of the experiment was carried out as planned. 
The time taken for the presence of fluorescing GFP to be evident under the 
fluorescence microscope varies greatly depending upon the specific GFP used in the 
experiment as well as the genes in question. Therefore since this is an experimental 
GFP which had not yet been tested, determining the most suitable time frame for 
fluorescence to be detected would still be worthwhile. After testing for fluorescence at 
3 hours, 6 hours, and 18 hours it became evident that result could be best obtained 18 
hours after induction (with samples taken at earlier times exhibiting no determinable 
differences to the negative control). 
Figure 6 shows confocal scanning fluorescence microscopy images of root tissue in 
both a negative control plant (A) and an mpGFP-containing plant sampled at five days 
old. Images B to D show the roots of plants containing pMP N-linked GFP before 
induction, 3 hours after induction, and 18 hours after induction. These images show 
that GFP is fluorescing strongly at the edges of cells, indicating its presence in the 
cytoplasm around the large vacuoles found in root cells; as would be expected for 
GFP constitutively expressed under the CaMV35S promoter. This evidence is further 
supported by the strong result of the negative control, indicating that the GFP visible 
in the images taken could not simply be the result of autofluorescence. It is therefore 
reasonable to conclude that the pMP N-linked GFP functions correctly. 
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(A) Negative Control (B) pMP N-link GFP before induction 
(C) pMP N-link GFP 3 hours after 
induction 
(D) pMP N-link GFP 18 hours after 
induction 
Figure 6 : Confocal scanning laser microscopy images used to capture 
GFP. Unfortunately only the positive control was able to be tested, how^ever 
the data provided has still proven to be useful. Images show Arabidopsis root 
tissue in a negative control plant which contains no GFP (A) which may be 
compared with the image of a GFP positive plant before ethanol induction (B) 
indicating that the expression of the alcohol inducible vector is not 'leaky'. 
GFP positive tissue 3 hours (C) and 18 hours (D) after ethanol induction 
together indicate show the time delay between induction and GFP detectable 
expression. (D) Also shows, by clear GFP expression in the cytoplasm 
surrounding the root cell vacuoles, that pMP N-link GFP functions correctly. 
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Part 4: Discussion 
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4. Discussion 
It was hypothesised that the binding of sterols to the START domain of various genes 
enabled those genes to be targeted to the nucleus of a cell, to enable the transcription 
of genes essential for normal plant development. It was further hypothesised that the 
essential START domain protein genes themselves may be mis-regulated in sterol-
deficient mutants, to produce the defective development seen. Such hypotheses are 
supported by the highly complex phenotypes of sterol mutants: for processes across 
such a wide range to be affected (multiple cotyledons, a lack of truly discrete vascular 
tissue, etc.) it is unlikely that the sole cause is abnormal membrane fluidity caused by 
deficient sterols, though this is still a likely important component of sterol function. 
Studies have shown that START domains are important in transport and synthesis of 
sterols and those structures which have been elucidated are also suggestive of this 
(Tsujishita and Hurley, 2000). This is however, not the only possible mechanism by 
which nuclear localisation could occur; many other different proteins could be 
involved in this process. The hypothesis of how the START domain functions would 
provide an elegant mechanism by which this control could be mediated. Though it has 
not been expressly shown that sterols do bind to plant START domain transcription 
factors in this way, a body of evidence suggests this to be the case in mammalian 
systems (Christensen and Straus, 2001), and the archetypal protein STaR binds plant 
sterols (Kallen et al. 1998). 
4.1. Creation of START::GFP Fusion Proteins 
The aim of the GFP studies in this dissertation was to attach a reporter (GFP) to 
several START domain proteins, and then induce expression of those proteins in a 
living plant. In this way the subcellular localisation of START domain proteins could 
be viewed, catalogued, and compared between wild type plants and those with a 
hydra mutant background. Unfortunately the formation of START: :GFP fusion 
proteins could not be completed, although the concept still has enormous potential. 
It would be beneficial i f GFP fusions could be made with the full length START 
domain proteins, thus it could be determined whether the presence of sterols 
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correlated with the nuclear localisation of the transcription factors studied, and i f 
defective sterol backgrounds correlated with a lack of nuclear localisation. This 
experimental model could also be improved by incorporating the native promoters for 
each gene into the constructs, preventing the constitutive expression shown by the 
CaMV35S promoter. Genes with mutations in their START domain could also be 
introduced and linked with GFP in the same way. Confocal microscopy could be used 
to determine what effect, i f any, this had on the subcellular localisation of the genes in 
question. Another approach to this study would be to identify any ligands for plant 
START domains, as they have thus far not been absolutely identified (Schrick et al. 
2004). 
Typically the inability to insert a gene in the correct orientation could be presumed to 
be a direct consequence of the inserted gene, when expressed, having such a 
deleterious effect upon the bacterium that it causes death and therefore no colony is 
formed from which a sample may be taken. Such toxicity of the inserted DNA would 
result in the data presented: low plasmid take-up, with those plasmids which have 
been multiplied containing the gene in an inexpressible form (i.e. 'backwards'). 
Although the use of the ale system was to ensure that the presence of alcohol was an 
essential component in initiating expression in plants, some leaky expression in 
bacteria may have been sufficient to induce toxic effects. Even i f this were the case 
then due to the number of colonies tested the expression would have to be unstable 
enough to be fatal to every single bacterium which took it up. However, this 
hypothesis could be disproven by examining the results shown in section 3.3.1 
(specifically those depicted in Figure 6, A and D). The positive control - GFP under 
the alcohol inducible promoter as these constructs would have been - was examined 
before induction and showed no visible signs of expression, appearing essentially 
indistinguishable from the negative control. Since 'leaky' expression would have been 
made manifest in the form of fluorescence it may be assumed that the alcohol 
inducibility of the promoter is functioning effectively in bacteria. 
In a situation where a correctly functional and previously proven system, which 
should be able to contain a construct that is not expressed unless a foreign chemical 
(alcohol) is present, proves incapable of being cloned, suspicion is then drawn to the 
earlier stages of the experiment. Firstly, it could not be possible for the primers 
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attached to the genes to be influencing the orientation of the inserted DNA because all 
ligations used at this failed stage are blunt-ended (for full details see section 2.3.2). 
This considered, could the inserted DNA have been from the TOPO plasmid (or some 
other DNA) instead of the desired gene? This is impossible as every stage of the 
cloning acts as a checkpoint to determine the 'identity' of the insert as it is brought 
through the experimental process. The cDNA originally used was amplified with 
gene-specific primers and shown by gel electrophoresis to produce a DNA product of 
the correct size. When colony PGR testing was carried out a completely unrelated set 
of gene-specific primers was used to determine whether or not each specific HD-
START domain gene was there (the real-time RT-PCR primers were used). 
Diagnostic digests indicated which specific START domain genes were present, and 
the actual sequencing data (used to check the orientation of the insert) clearly shows 
the genes to be present but in 'reverse'. 
Therefore there is apparently no obvious explanation as to why the START domain 
genes would only be able to be inserted into the alcohol inducible vectors in the 
incorrect orientation, although the probability of the obtained results being down to 
chance is so low as to be negligible. Therefore there are evidently unidentified factors 
influencing the ability to clone these START::GFP fusions into the ale system, 
however it would likely be inefficient to investigate them further at this time when 
other lines of investigation are still available through which to glean more valuable 
information about the roles of sterols and START domain genes in plant 
development. 
4.2. Real-time RT-PCR Assays 
Although the real-time RT-PCR studies proved more successful than the HD-START 
domain gene cloning, the results are difficult to interpret. The aim of the real-time 
RT-PCR studies was to obtain more evidence to help determine i f the expression of 
the START domain transcription factors is mis-regulated in sterol-defective mutants. 
The real-time RT-PCR assays provided valuable data on the difference in steady state 
transcription levels of five HD-START domain genes in both the hydra 2 and the 
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hydra 1-2 mutants as compared with the wild type Arabidopsis plants. 
The results provide evidence that the mRNA levels of the studied genes can vary 
greatly from those exhibited in the wild type, the greatest example being that of the 
observed steady state transcription level of PHABULOSA on day 9 of development in 
hydra 1-2, which showed PHB RNA levels 359% that of the wild type. For other 
genes, the differences were less dramatic, but were still significant, particularly when 
contrasted with the results for the positive control (housekeeping gene ACT2). 
Therefore it is evident that the study of these steady state transcription levels did 
provide some evidence that defective sterol profiles of hydra mutants have an effect 
on the levels of mRNA present for the START domain proteins. The experiment also 
posed some questions: i f the hydra mutants are similar enough consistently to exhibit 
the same pattern of upregulation and downregulation with time then why does hydra 
1-2, the mutation further downstream in the sterol biosynthesis pathway, exhibit a 
more exaggerated pattern of differences in START domain gene steady state 
transcription levels than hydra 21 Moreover, a key question is, what is the biological 
basis, i f any, for the observed mis-regulation? 
One possibility is that the hydra 1-2 mutation itself has a greater effect than the hydra 
2 mutation either directly upon START domain gene transcription or indirectly 
influences transcription by affecting other molecules involved in transcriptional 
regulation. This is somewhat unexpected, since the hydra 1-2 mutation is located 
downstream of the hydra 2 mutation in the sterol biosynthetic pathway (see Figure 1), 
which would might lead us to the assumption that it would have a lesser effect on the 
seedling. In addition, the phenotypes of the hydra mutants are very similar; this again 
could be anticipated due to the proximity in which the individual mutations occur. 
This in turn makes it seem unlikely that two such closely related mutations could 
cause the transcription of genes - themselves implicated in the control of transcription 
- to differ as shown. Further to this it must still be remembered that mRNA levels are 
not synonymous with gene expression, and that any manner of other factors could be 
affecting the actual expression of these START domain genes both before and after 
transcription. However, it is possible that the observed different sterol profiles in the 
hydra 1-2 and hydra2 mutants (Souter ef a/. 2002) could be sufficient to affect 
48 
differentially the transcription of key transcription factors, such as those shown. The 
biological basis for this remains unclear, but given the defective hormone signalling, 
tissue organization and differentiation processes seen in these mutants, the disruption 
of gene transcription is not unexpected. For example, the observed down-regulation of 
AiMLl, a gene expressed in the epidermal layers of the seedling, in hyd2 may be the 
consequence of the observed defective differentiation of the epidermis in at least some 
hyd2 plants (Topping ef al. 1997; Souter et al. 2002). There is currently no information 
on the transcriptional control of the START domain protein genes by hormones. 
In order to be convinced of the results obtained thus far it would be greatly beneficial 
i f these real-time RT-PCR studies were to be repeated with additional samples. This 
would ensure that the observed trends discussed here are truly representative of the 
mRNA levels typically present in the hydra mutant seedlings. In addition, the data as 
collected in the course of this experiment carmot be used to identify the cause of these 
changes in steady state transcription levels. To tackle this and further elucidate the 
mechanisms and processes involved, further avenues of research must be followed 
(some are discussed in section 4.3) 
Quality and Reliability of Results 
When analysing the data obtained through real time RT-PCR the quality of the results 
themselves cannot be ignored. Indeed, the tentative conclusions drawn above could be 
rendered unusable i f the quality of the data gathered is in dispute. 
What is most noticeable about the results as they have been presented so far are the 
unexpectedly large variations in the individual results obtained, depicted graphically 
as the large error bars visible on Figure 5. This degree of variability amongst the 
results could suggest that the experiment was less precise than it should have been 
(and therefore, by extension, less reliable) however several key points when 
considered together are indicative of a different and altogether more positive 
explanation. 
Firstly, were the large variations in the obtained results due to poor experimental 
procedure, low quality samples, or poorly optimised PGR conditions, the effect would 
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surely be that all data obtained shared large error bars. Whilst it is true that some of 
the data points are flanked by these large error bars this is not always the case. Not 
only are there many data points for HD-START domain genes which display 
comparatively very little variation (such as; GL2, hydra 2, day 13 and REV, hydra 1-
2, day 13 - both in Figure 5) but the data obtained for the positive control, 
housekeeping gene ACT2, was consistently flanked by comparatively very small 
errors. These small standard deviations appear to indicate that the experiment itself is 
robust and the results simply reflect the differing levels of variation between samples. 
Furthermore, such variation is in itself cause for additional examination. 
The most noticeable pattern to emerge when analysing the standard deviations is that 
they varied in an almost characteristic pattern according to whether the variation was 
for wild type, hydra 2, or hydra 1-2 samples. The standard deviation amongst the 
results obtained for wild type seedlings averaged at 7% above or below the total 
mRNA content determined by real-time RT-PCR. This is demonstrated in Figure 5, 
A-F as the broken lines above and below the 100% mark as shown on the y-axes, and 
was almost invariably lower than the standard deviations for the hydra mutant results 
for any given test. In the majority of the real time RT-PCR runs the samples with the 
next greatest standard deviation in their results were the hydra 2 mutants (with an 
average of 10% above and below) and the samples exhibiting the greatest standard 
deviation were the hydra 1-2 mutants. It could be hypothesised that, since the hydra 
mutants by their highly variable phenotypes (Topping ef a/. 1997; Schrick ef a/. 2000, 
Souter et al. 2002) appear to indicate unpredictable changes in the levels and timing of 
gene transcription to a degree, greater variability in the actual levels of mRNA 
between samples would be anticipated. Although such variability would be minimised 
(and therefore produce smaller error bars) were all the samples of hydra 2 or of hydra 
1-2 seedling RNA to be mixed before being dispensed into aliquots for each PCR run, 
this would simply mask the variability of the data, and knowledge of this variability is 
essential when analysing both the nuances and reliability of the results. 
In the case of the hydra 1-2 mutants the increased proportion of error inherent in the 
results may be a direct consequence of the smaller sample size drawn upon for real 
time RT-PCR studies (it was mentioned in section 2.2.1 that the hydra 1-2 seeds had a 
lower germination frequency than the hydra 2 seeds and therefore only a third as 
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many samples were able to be tested). Strength is added to this argument by the 
knowledge that the variation for hydra 1-2 seedlings was slightly greater than for the 
hydra 2 seedlings even iov ACT2. Therefore, although several patterns have emerged 
from which it is possible to draw conclusions, the often large standard errors must still 
be considered when analysing the data. 
In summary, data have been obtained that suggest that the expression of key 
transcription factors of the START domain family are mis-regulated in sterol-
defective mutants. Given the phenotypes of the hydra mutants, this may be the 
consequence of the observed defects in hormone signalling, tissue specification and 
tissue patterning, which might be expected to affect transcriptional profiles, in a way 
that would be expected to be independent of a direct role for sterols in the control of 
gene regulation The data for ACT2 has demonstrated that this differential profile of 
mRNA levels in the hydra mutants is not common to all genes, thereby adding to the 
evidence suggesting a specific role for genes which utilise sterols. Another possible 
explanation for these patterns of differences is that, as stated previously, different 
sterol profiles within each of the mutants may in turn affect some sterol-dependant 
processes differently. It was not possible to determine more direct possible roles for 
sterols in transcription factor localization, and this should be the subject of future 
studies. 
4.3. Directions for Future Research 
An obvious direction for future work would be the completion of GFP::START 
domain protein construction, although evidently the experimental protocol suggested 
here will need to be re-examined. Once created these fusion proteins could be tested 
in vivo not only in the hydra mutants but in other sterol defective mutants. In this way 
more evidence regarding the subcellular localisation of START domain proteins could 
be obtained, allowing more definite conclusions regarding the role of sterols in 
START domain protein localisation. 
This aim could be further investigated by the creation of START: :GFP fusion proteins 
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in which the START domain itself has been altered by site-directed mutagenesis. 
Confocal scanning laser microscopy could then be used to examine the effect this 
would have upon subcellular localisation of the protein. In this way the necessity of 
the putative sterol-binding domain in subcellular localisation may be both determined 
and observed across both the wild-type and sterol deficient plants. 
In order to obtain more definitive results it would be beneficial both to calculate a 
more accurate average by continuing experiments in this way, and to determine i f the 
observed variation is indeed a result of variations in gene transcription levels and 
timing between individual hydra mutants. The former would provide a more accurate 
average by increasing the sample size, and could only be improved by also testing 
with a more sensitive PGR method. The latter would, however, prove more 
challenging as ideally RNA extractions should be carried out on individual mutants, 
and would also obviously not permit comparisons across time for individual plants, 
since RNA extraction is a destructive process. Further to this approach the data 
obtained through the real-time RT-PCR assays could be validated by visualising gene 
expression in hydra mutants. This may be done either by using in situ mRNA 
localisation, or by carrying out promoter: :GUS fusion analyses of the HD-START 
domain protein genes. 
An invaluable line of research would be, as suggested previously, the identification of 
those ligands which bind to the sterol binding domains in the genes tested. Moving 
away from those avenues of research dealt with directly during this project a range of 
other approaches could be used, including determining the extent to which the 
transport mechanisms of the mutant seedlings are affected (as is evidenced by the lack 
of response to the exogenous application of BRs, shown by Topping et al., 1997). 
A combination of these and other studies in the future may prove invaluable in fully 
characterising the effect of sterol mutations upon plant development. In furthering the 
bodies of evidence regarding both the transcriptional regulation and the subcellular 
localisation of START domain proteins across wild type and sterol deficient plants 
this aim may begin to be achieved. 
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6. Appendices 
6.1. Appendix A - Sequences 
*> AtML 1 cDNA Sequence 
• GL2 cDNA Sequence 
• PHB cDNA Sequence 
• PHV cDNA Sequence 
• R E V cDNA Sequence 
• R E V Amplified Sequence Aligned with cDNA Sequence and TAIR 
Sequence 
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A t M L l c D N A S e q u e n c e 
A T G T A T C A T C C A A A C A T G T T C G A A T C T C A T C A T C A T A T G T T C G A T A T G A C G 
C C G A A A A A C T C C G A A A A C G A T T T G G G T A T C A C C G G G A G C C A C G A A G A G G 
A T T T C G A G A C T A A G T C C G G C G C A G A A G T C A C C A T G G A G A A T C C T T T A G A A 
G A A G A G C T T C A A G A T C C T A A T C A G C G T C C C A A C A A A A A G A A G C G T T A C C A 
C C G T C A C A C A C A A C G C C A G A T T C A A G A G C T A G A G T C G T T C T T C A A G G A A T 
G T C C T C A T C C A G A C G A T A A G C A A A G A A A G G A G C T G A G T C G C G A G C T A A G 
C T T A G A A C C T C T T C A A G T C A A G T T T T G G T T C C A A A A C A A A C G C A C T C A A A T 
G A A G G C A C A A C A T G A G A G G C A C G A G A A C C A G A T A C T G A A G T C A G A A A A T 
G A C A A G C T C C G A G C A G A G A A C A A T A G G T A C A A G G A T G C T C T A A G C A A C G 
CAACATGCCCAAACTGTGGTGGTCCGGCAGCTATAGGAGAAATGTCCTTC 
G A C G A A C A G C A T T T A A G G A T C G A A A A T G C T C G T T T A C G C G A A G A G A T T G A 
C A G A A T C T C T G C C A T A G C T G C T A A A T A C G T A G G G A A G C C T T T A A T G G C T A 
ATTCCTCTTCTTTCCCTCAGCTCTCTTCTTCACACCACATTCCCTCGCGCTC 
G C T T G A T C T T G A A G T T G G G A A C T T T G G G A A C A A T A A C A A T A G C C A C A C T G 
GTTTCGTTGGGGAAATGTTTGGAAGCAGCGACATTTTGAGGTCGGTTTCGA 
TACCTTCTGAGGCTGATAAGCCTATGATTGTTGAGTTAGCTGTTGCAGCAA 
TGGAAGAGCTTGTGAGAATGGCTCAAACTGGTGATCCCTTATGGGTTTCA 
A G C G A T A A T T C T G T T G A G A T T C T C A A T G A A G A A G A G T A T T T T A G G A C G T T T 
C C T A G A G G A A T T G G A C C G A A A C C T A T C G G T T T G A G A T C A G A A G C T T C A A G 
A G A G T C T A C T G T T G T T A T C A T G A A T C A T A T C A A T C T C A T T G A G A T T C T A A T 
G G A T G T G A A T C A A T G G T C T A G T G T G T T C T G C G G G A T T G T A T C A A G A G C A T T 
GACTCTAGAAGTTCTCTCAACTGGCGTAGCAGGGAACTACAATGGGGCAT 
TGCAAGTGATGACAGCAGAGTTCCAAGTCCCATCGCCGCTTGTCCCTACTC 
G T G A G A A C T A C T T T G T A A G G T A C T G T A A A C A G C A C A G T G A C G G T A T T T G G 
GCGGTTGTGGATGTCTCTTTGGACAGCCTAAGACCAAGTCCGATCACTAG 
A A G C A G A A G A A G A C C C T C T G G T T G T C T G A T T C A A G A A T T G C A G A A T G G T T 
A C T C C A A G G T G A C A T G G G T A G A G C A T A T T G A G G T G G A T G A T A G A T C G G T T 
C A C A A C A T G T A T A A A C C G T T G G T T A A T A C C G G T T T A G C T T T C G G T G C A A A 
ACGTTGGGTGGCTACACTTGACCGCCAATGTGAGCGGCTCGCCAGTTCCA 
TGGCCAGCAACATTCCGGCTTGTGATCTTTCCGTGATAACGAGTCCTGAGG 
G G A G A A A G A G C A T G C T G A A A C T A G C G G A G A G A A T G G T G A T G A G C T T C T G 
TACCGGAGTCGGCGCGTCAACTGCGCATGCCTGGACTACATTGTCGACCA 
CAGGATCCGACGACGTTCGGGTCATGACCCGAAAGAGCATGGATGATCCG 
GGAAGACCTCCAGGCATCGTTCTCAGCGCCGCTACTTCTTTCTGGATCCCT 
G T A G C T C C A A A A C G A G T G T T C G A T T T T C T C A G A G A T G A A A A C T C A A G A A G 
C G A G T G G G A T A T A C T T T C C A A T G G A G G C T T G G T T C A A G A A A T G G C T C A T A 
TCGCAAATGGTCGTGATCCTGGGAATAGTGTCTCCTTGCTTCGAGTCAATA 
G T G G G A A C T C A G G G C A G A G C A A C A T G T T G A T C T T A C A A G A A A G T T G T A C G 
G A C G C A T C A G G G T C C T A T G T G A T A T A C G C A C C A G T T G A T A T A A T A G C T A T 
GAACGTTGTCCTGAGTGGTGGTGATCCGGATTATGTCGCTTTGTTACCATC 
CGGATTCGCTATTTTGCCGGATGGCTCTGCTAGAGGAGGAGGAGGTAGTG 
C T A A T G C C A G T G C T G G A G C C G G A G T T G A A G G A G G A G G A G A G G G G A A T A A 
TCTTGAAGTGGTTACTACTACTGGGAGTTGTGGCGGTTCACTACTCACAGT 
TGCGTTTCAGATACTTGTTGACTCTGTTCCTACCGCTAAACTCTCTCTCGGT 
T C A G T T G C T A C A G T C A A T A G T C T G A T C A A A T G C A C T G T C G A G C G G A T T A A 
AGCCGCTCTGGCCTGCGACGGAGCCTAATCGATGTTTTCGGAAGGTAAGA 
GTGAAAGGG 
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G L 2 c D N A S e q u e n c e 
A T G T C A A T G G C C G T C G A C A T G T C T T C C A A A C A A C C C A C C A A A G A C T T T T T C 
TCCTCTCCAGCCCTCTCTCTATCTCTCGCTGGGATATTCCGGAATGCATCCT 
CCGGCAGCACCAACCCTGAGGAGGATTTCCTGGGCAGAAGAGTAGTTGAC 
GATGAGGATCGCACTGTGGAGATGAGCAGCGAGAACTCAGGACCCACGA 
G A T C C A G A T C A G A G G A G G A T T T G G A G G G T G A G G A T C A C G A C G A T G A G G A 
G G A G G A A G A G G A G G A C G G C G C A G C T G G A A A C A A G G G C A C T A A T A A G A G 
A A A G A G G A A G A A G T A T C A T C G T C A C A C C A C C G A T C A G A T C A G A C A C A T G 
G A A G C G C T A T T C A A A G A G A C A C C A C A T C C G G A C G A G A A G C A A A G A C A G C 
AGCTGAGCAAGCAACTAGGGCTGGCCCCTCGCCAGGTCAAGTTCTGGTTC 
C A A A A C C G C C G C A C A C A G A T C A A G G C T A T T C A A G A A C G G C A C G A G A A C T 
C C C T G C T C A A G G C G G A A C T A G A G A A G C T G C G A G A G G A A A A C A A A G C C A T 
GAGGGAGTCTTTTTCCAAGGCTAATTCCTCCTGCCCCAACTGCGGAGGAG 
GCCCCGATGATCTCCACCTCGAAAACTCCAAACTGAAAGCCGAGCTCGAT 
AAGCTTCGTGCAGCTCTTGGACGCACTCCCTATCCCCTGCAGGCTTCATGC 
TCCGACGATCAAGAACACCGTCTCGGCTCTCTCGATTTCTACACGGGCGTC 
TTTGCCCTCGAGAAGTCCCGTATTGCCGAGATTTCTAACCGAGCCACCCTT 
GAACTCCAGAAGATGGCCACCTCAGGCGAACCTATGTGGCTCCGCAGCGT 
T G A G A CT G GC C GTGAGATTC TC AACTACGATGAGTACCTCAAGGAGTTTC 
CCCAAGCGCAAGCCTCTTCGTTTCCTGGAAGGAAAACCATCGAAGCATCT 
A G A G A T G C G G G G A T T G T G T T T A T G G A C G C A C A T A A A C T T G C C C A G A G T T T 
C A T G G A C G T G G G A C A A T G G A A A G A G A C A T T T G C A T G C T T G A T C T C A A A G G 
CTGCAACGGTCGATGTTATCCGGCAAGGCGAAGGGCCTTCACGGATCGAC 
GGGGCTATTCAGCTGATGTTCGGAGAGATGCAGCTGCTCACTCCGGTCGT 
CCCCACAAGAGAAGTGTACTTCGTGAGAAGCTGCCGGCAGCTGAGCCCTG 
AGAAATGGGCAATAGTGGACGTCTCGGTCTCCGTGGAGGACAGCAACAC 
GGAGAAGGAGGCTTCTCTTCTGAAATGTCGAAAACTCCCCTCCGGTTGCA 
TCATCGAGGACACCTCCAACGGTCACTCCAAGGTCACCTGGGTGGAGCAC 
CTCGACGTGTCTGCATCCACAGTTCAGCCTCTCTTCCGCTCCTTAGTCAAC 
ACCGGTTTGGCCTTTGGGGCTCGACACTGGGTCGCCACCCTTCAGCTCCAT 
TGCGAACGCCTTGTCTTCTTCATGGCTACCAACGTCCCCACCAAAGACTCT 
CTCGGAGTTACAACTCTTGCCGGGAGAAAGAGTGTGCTGAAGATGGCTCA 
G A G A A T G A C A C A A A G C T T C T A C C G C G C C A T T G C T G C A T C A A G C T A C C A T C 
A A T G G A C C A A A A T C A C C A C C A A A A C T G G A C A A G A C A T G C G G G T T T C T T C C 
AGGAAGAACCTTCATGATCCTGGCGAGCCCACGGGAGTCATTGTCTGCGC 
TTCTTCTTCGCTGTGGTTACCTGTTTCTCCAGCTCTTCTCTTCGATTTCTTTA 
GAGATGAAGCTCGTCGGCATGAGTGGGATGCTTTGTCAAACGGAGCTCAT 
G T T C A G T C T A T T G C A A A C T T A T C C A A G G G A C A A G A C A G A G G C A A C T C A G T 
G G C A A T C C A G A C A G T G A A A T C G A G A G A A A A G A G C A T A T G G G T G C T G C A A 
GACAGCAGCACTAACTCGTATGAGTCGGTGGTGGTATACGCTCCCGTAGA 
T A T A A A C A C G A C A C A G C T G G T G C T C G C G G G A C A T G A T C C A A G C A A C A T C C 
AAATCCTCCCCTCTGGATTCTCAATCATACCTGATGGAGTAGAGTCACGGC 
C A C T G G T A A T A A C G T C T A C A C A A G A C G A C A G A A A C A G C C A A G G A G G G T C 
GCTCCTGACACTCGCCCTCCAAACCCTCATCAACCCTTCTCCTGCAGCAAA 
GCTGAATATGGAGTCTGTGGAATCCGTGACAAACCTCGTCTCAGTCACAC 
T A C A C A A C A T T A A G A G A A G T C T A C A A A T C G A A G A T T G C T G A T G A C A A G T C 
A C A G C A G A T A T T A T T T A C C T A T 
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A T G A T G A T G G T C C A T T C G A T G A G C A G A G A T A T G A T G A A C A G A G A G T C G C C 
G G A T A A A G G G T T A G A T T C C G G C A A G T A T G T G A G G T A C A C G C C G G A G C A A 
GTGGAAGCTCTCGAGAGAGTTTACACTGAGTGTCCTAAGCCAAGTTCTCT 
A A G A A G A C A A C A A C T C A T A C G T G A A T G T C C G A T T C T C T C T A A C A T C G A G C 
C T A A G C A G A T C A A A G T T T G G T T T C A G A A C C G C A G A T G T C G T G A G A A G C A G 
A G G A A A G A A G C T G C T C G T C T T C A A A C A G T G A A C A G A A A A C T C A A T G C C A T 
G A A C A A A C T C T T G A T G G A A G A G A A T G A T C G T T T G C A G A A G C A A G T T T C T A 
A C T T G G T C T A T G A G A A T G G C C A C A T G A A A C A T C A A C T T C A C A C T G C T T C T G 
GGACGACCACAGACAACAGCTGTGAGTCTGTGGTCGTGAGTGGTCAGCAA 
C A T C A A C A G C A A A A C C C A A A T C C T C A G C A T C A G C A A C G T G A T G C T A A C A A 
CCCAGCAGGACTCCTTTCTATAGCAGAGGAGGCCCTAGCAGAGTTCCTTT 
CCAAGGCTACAGGAACTGCTGTTGACTGGGTTCAGATGATTGGGATGAAG 
CCTGGTCCGGATTCTATTGGCATAGTCGCTATTTCGCGCAACTGCAGCGGA 
ATTGCAGCACGTGCCTGCGGCCTCGTGAGTTTAGAACCCATGAAGGTTGC 
TGAAATTCTCAAAGATCGTCCATCTTGGCTCCGAGATTGTCGAAGTGTGG 
ATACTCTGAGTGTGATACCTGCTGGAAACGGTGGGACGATCGAGCTTATT 
TACACGCAGATGTATGCTCCTACGACTTTAGCAGCAGCTCGTGACTTTTGG 
A C G C T G A G A T A T A G C A C A T G T T T G G A A G A T G G A A G C T A T G T G G T T T G T G A 
AAGGTCGCTTACTTCTGCAACTGGTGGCCCCACTGGGCCACCTTCTTCAAA 
CTTTGTGAGAGCTGAAATGAAACCAAGCGGGTTTCTCATCCGTCCTTGCG 
ATGGTGGTGGTTCCATTCTCCACATTGTTGATCATGTTGATCTGGATGCCT 
GGAGTGTCCCTGAAGTCATGAGGCCTCTCTATGAATCATCGAAGATTCTTG 
C T C A G A A A A T G A C T G T T G C T G C T T T G A G A C A T G T A A G A C A A A T T G C A C A A 
GAAACAAGTGGAGAAGTTCAGTATGGTGGAGGGCGCCAACCTGCGGTTTT 
A A G A A C C T T C A G T C A A A G A C T C T G T C G G G G T T T C A A T G A T G C T G T T A A T G 
GTTTTGTGGATGATGGATGGTCACCAATGGGTAGCGATGGTGCAGAGGAT 
GTTACTGTAATGATAAACTTGTCCCCTGGGAAGTTTGGTGGGTCTCAGTAC 
GGTAATTCATTCCTTCCAAGCTTTGGTAGTGGCGTGCTTTGTGCCAAGGCA 
TCTATGTTGCTTCAGAACGTTCCACCCGCTGTGCTGGTTCGATTCCTTAGA 
GAACACCGATCTGAATGGGCTGATTATGGCGTGGATGCTTATGCTGCTGC 
ATCGCTCAGAGCAAGTCCTTTTGCTGTTCCTTGTGCTAGAGCTGGGGGGTT 
C C C A A G T A A C C A A G T C A T T C T T C C T C T T G C G C A G A C A G T T G A A C A T G A A G 
AGTCACTTGAGGTGGTTAGACTTGAAGGTCACGCTTACTCACCCGAAGAC 
ATGGGTTTAGCTCGGGATATGTATTTGCTACAGCTTTGTAGCGGTGTTGAT 
GAAAATGTGGTTGGAGGTTGTGCACAGCTTGTATTTGCCCCTATCGATGAA 
TCATTTGCTGATGATGCACCTTTGCTTCCTTCCGGTTTCCGCATCATACCTC 
T T G A A C A G A A A T C T A C T C C G A A C G G T G C A T C T G C A A A C C G T A C C C T G G A T 
TTAGCCTCAGCTTTAGAAGGATCCACACGTCAAGCTGGTGAAGCCGACCC 
A A A T G G C T G T A A C T T T A G G T C G G T A C T A A C C A T A G C A T T C C A G T T C A C A T T 
T G A T A A C C A T T C A A G A G A C A G T G T T G C T T C A A T G G C A C G T C A G T A C G T G C 
GAAGCATAGTAGGATCGATTCAGAGGGTTGCTCTAGCCATTGCTCCTCGT 
CCTGGCTCCAATATCAGTCCAATATCTGTTCCCACT 
62 
P H V c D N A S e q u e n c e 
ATGATGGCTCATCACTCCATGGACGATAGAGACTCTCCTGATAAAGGATTTGA 
TTCCGGCAAGTACGTTAGATACACGCCGGAACAAGTTGAAGCTCTTGAGAGA 
GTTTATGCTGAGTGTCCTAAACCTAGCTCTCTGAGAAGACAACAGCTTATTCG 
TGAATGTCCCATTCTCTGTAACATCGAGCCTCGACAGATCAAAGTTTGGTTCC 
AGAATCGCAGATGTCGAGAGAAGCAGAGGAAAGAGTCAGCTCGTCTTCAGAC 
AGTGAACAGGAAGCTGAGTGCTATGAACAAGCTTTTGATGGAAGAGAATGAT 
CGTTTGCAGAAGCAAGTCTCCAACTTGGTTTATGAGAATGGATTCATGAAACA 
TCGAATCCACACTGCTTCTGGGACGACCACAGACAACAGCTGTGAGTCTGTG 
GTCGTGAGTGGTCAGCAACGTCAGCAGCAAAACCCAACACATCAGCATCCTC 
AGCGTGATGTTAACAACCCAGCTAATCTTCTCTCGATTGCGGAGGAGACCTTG 
GCGGAGTTCCTTTGCAAGGCTACAGGAACTGCTGTCGACTGGGTCCAGATGA 
TTGGGATGAAGCCTGGTCCGGATTCTATTGGTATCGTAGCTGTTTCACGCAAC 
TGCAGTGGAATAGCAGCACGTGCCTGTGGCCTCGTGAGTTTAGAACCCATGA 
AGGTCGCTGAAATCCTCAAAGATCGTCCATCTTGGTTCCGTGACTGTCGATGT 
GTCGAGACTCTGAATGTTATACCCACTGGAAATGGTGGTACTATCGAGCTTGT 
CAACACTCAGATTTATGCTCCTACAACATTAGCAGCAGCTCGTGACTTTTGGA 
CGCTGAGATATAGTACAAGTCTAGAAGATGGAAGCTATGTGGTCTGTGAGAG 
ATCACTCACTTCTGCAACTGGTGGCCCCAATGGTCCACTTTCTTCAAGCTTCGT 
GAGAGCCAAAATGCTGTCAAGCGGGTTTCTTATCCGTCCTTGTGATGGTGGTG 
GTTCCATTATTCACATCGTTGATCATGTGGACTTGGATGTCTCAAGTGTTCCTG 
AAGTCCTCAGGCCTCTTTATGAGTCTTCCAAAATCCTTGCTCAAAAAATGACT 
GTCGCTGCTCTGAGACATGTGCGCCAAATTGCTCAAGAGACTAGTGGAGAAG 
TCCAGTATAGTGGTGGACGCCAGCCTGCAGTTTTAAGGACTTTCAGCCAGAG 
ACTCTGCCGGGGTTTCAATGATGCTGTAAATGGTTTTGTCGATGATGGATGGT 
CTCCAATGAGTAGTGATGGAGGAGAGGATATTACGATCATGATTAACTCTTCC 
TCTGCTAAATTTGCTGGCTCCCAATACGGTAGCTCATTTCTTCCAAGTTTTGGA 
AGTGGTGTCCTCTGTGCCAAAGCTTCTATGCTGTTGCAGAATGTTCCACCCCT 
TGTATTGATTCGGTTCCTGAGAGAACACCGAGCTGAATGGGCAGACTATGGT 
GTCGATGCCTATTCTGCTGCATCTCTCAGAGCAACTCCATATGCTGTTCCATG 
CGTCAGAACCGGTGGGTTCCCGAGTAACCAAGTCATTCTTCCTCTCGCACAGA 
CACTCGAACATGAAGAGTTTCTCGAAGTGGTTAGACTTGGAGGTCATGCTTAC 
TCACCTGAAGACATGGGCTTATCCCGGGATATGTATTTACTGCAGCTTTGTAG 
CGGCGTTGATGAAAATGTGGTTGGAGGTTGTGCTCAGCTTGTCTTTGCCCCAA 
TCGATGAATCATTTGCTGATGATGCACCTTTGCTTCCTTCTGGTTTCCGTGTCA 
TACCACTCGACCAAAAAACAAATCCGAATGATCATCAATCTGCAAGTCGAAC 
ACGGGATCTAGCATCGTCCCTAGATGGTTCCACCAAAACCGATTCGGAAACA 
AACTCTAGATTGGTCTTAACAATAGCCTTCCAGTTCACGTTTGATAACCATTC 
CAGAGACAATGTTGCTACAATGGCGAGACAGTATGTGAGGAACGTTGTTGGT 
TCGATTCAGAGAGTGGCTCTAGCCATTACGCCTCGTCCTGGCTCAATGCAACT 
TCCCACTTCCCCTGAAGCTCTCACTCTTGTCCGTTGGATCACCCGTAGTTACAG 
TATTCATACAGGTGCAGATCTGTTTGGAGCTGATTCTCAGTCCTGTGGAGGAG 
ACACATTGCTTAAGCAACTCTGGGACCATAGTGATGCCATATTGTGCTGCTCC 
CTGAAAACTAATGCCTCACCGGTATTCACATTTGCAAACCAAGCTGGTTTAGA 
CATGCTTGAAACTACACTTGTGGCACTTCAGGATATAATGCTCGACAAAACAC 
TTGATGACTCTGGTCGTAGAGCTCTTTGCTCCGAGTTCGCCAAGATCATGCAG 
CAGGGATATGCGAATCTTCCGGCAGGAATATGTGTGTCGAGCATGGGCAGAC 
CGGTTTCGTATGAGCAAGCGACGGTGTGGAAAGTTGTTGATGACAACGAATC 
AAACCACTGCTTGGCTTTTACCCTCGTTAGTTGGTCGTTTGTTTGA 
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REVQLUIA cDNA c lone BX830562 f r o n genoscppe 
p i n k = START d o m a i n 
o r a n g e = R E V ( f o r 2 ) 
p u r p l e = R E V ( f o r 3 ) a n d R E V ( r e v 3 ) 
r e d = R E V ( r e v 2 ) 
g r e e n - F L - R E V / N T A I L G F P ( F O R ) B A M 
l i g h t g r e e n = F L - R E V/NTAILGrP ( R E V )BAM 
1 A T G G A G A T G G C G G T G G C T A A CCACCGTGAG A G A A G C A G T G A C A G T A T G A A 
51 T A G A C A T T T A G A T A G T A G C G G T A A G T A C G T T A G G T A C A C A G C T G A G C A A G 
101 TCGAGGCTCT T G A G C X J T G T C T A C G C T G A G T G T C C T A A G C C T A G C T C T C T C 
151 C G T C G A C A A C A A T T G A T C C G T G A A T G T T C C A T T T T G G C C A A T A T T G A G C C 
201 T A A G C A G A T C A A A G T C T G G T T T C A G A A C C G C A G T G T C C G A G A T A A G C A G A 
251 G G A A A G A G G C GTCGAGGCTC C A G A G C G T A A A C C G G A A G C T C T C T G C G A T G 
301 A A T A A A C T G T T G A T G G A G G A G A A T G A T A G G T T G C A G A A G C A G G T T T C T C A 
351 GCTTGTCTGC GAAAATGGAT A T A T G A G A C A G C A G C X I A A C T A C T G T T G T T A 
401 A C G A T C C A A G C T G T G A A T C T G T G G T C A C A A C T C C T C A G C A T T C G C T T A G A 
451 G A T G C G A A T A GTCCTGCTGG ATTGCTCTCA ATCGCAGAGG AGACTTTGGC 
501 AGAGTTCCTA T C C A A G G C T A CAGGAACTGC TGTTGATTGG GTTCAGATGC 
551 CTGGGATGAA GCCTGGTCCG GATTCGGTTG GCATCTTTGC CATTTCGCAA 
601 AGATGCAATG GAGTGGCAGC TCGAGCCTGT GGTCTTGTTA GCTTAGAACC 
651 TATGAAGATT GCAGAGATCC TCAAAGATCG GCCATCTTGG TTCCGTGACT 
701 GTAGGAGCCT TGAAGTTTTC ACTATGTTCC CGGCTGGTAA TGGTGGCACA 
751 ATCGAGCTTG TTTATATGCA GACGTATGCA CCAACGACTC TGGCTCCTGC 
801 CCGCGATTTC TGGACCCTGA GATACACAAC GAGCCTCGAC AATGGGAGTT 
851 TTGTGGTTTG TGAGAGGTCG CTATCTGGCT CTGGAGCTGG G C C T A A T G C T 
901 GCTTCAGCTT CTCAGTTTGT GAGAGCAGAA ATGCTTTCTA GTGGGTATTT 
951 AATAAGGCCT TGTGATGGTG GTGGTTCTAT TATTCACATT, GTCGATCACC 
1001 TTAATCTTGA GGCTTGGAGT GTTCCGGATG TGCTTCGACC CCTTTATGAG 
1051 TCATCCAAAG TCGTTGCACA AAAAATGACC ATTTCCGCGT TGCGGTATAT 
1101 CAGGCAATTA G C C C A A G A G T C T A A T G G T G A A G T A G T G T A T G G A T T A G G A A 
1151 G G C A G C C T G C T G T T C T T A G A A C C T T T A G C C A A A G A T T A A G C A G G G G C T T C 
1201 A A T G A T Q C G G TTAATGGGTT T G G T G A C G A C G G G T G G T C T A CGATGCATTG 
1251 T G A T G G A G C G GAAGATATTA T C G T T G C T A T TAACTCTACA A A G C A T T T G A 
1301 A T A A T A T T T C TAATTCTCTT TCGTTCCTTG GAGGCGTGCT CTGTGCCAAG 
1351 G C T T C A A T Q C TTCTCrAAAA TGTTCCTCCT GOGGTTTrGA T C C X 3 G T T C C T 
1401 T A G A G A G C A T C G A T C T G A G T G G G C T G A T T T C A A T G T T G A T G C A T A T T C C G 
1451 C T G C T A C A C T T A A A G C T G G T A G C T T T G C T T A T C C G G G A A T GAGACCAACA 
1501 A G A T T C A C T G G G A G T C A G A T C A T A A T G C C A C T A G G A C A T A C A A T T G A A C A 
1551 C G A A G A A A T G C T A G A A G T T G T T A G A C T G G A A G G T C A T T C T C T T G C T C A A G 
1601 A A G A T G C A T T T A T G T C A C G G G A T G T C C A T C T C C T T C A G A T T T G T A C C G G G 
1651 A T T G A C G A G A A T G C C G T T G G A G C T T G T T C T G A A C T G A T A T T T G C T C C G A T 
1701 TAATGAGATG T T C C C G G A T G A T G C T C C A C T TGTTCCCTCT G G A T T C X : G A G 
1751 T C A T A C C C G T T G A T G C T A A A A C G G G A G A T G T A C A A G A T C T G T T A A C C G C T 
1801 A A T C A C C G T A C A C T A G A C T T A A C T T I T A G C OTTGAAGTCG GTCCATCACr 
1851 T G A G A A T G C T T C T G G A A A C T C T T T T T C T A G C T C A A G C T C G A G A T G T A T T C 
1901 T C A C T A T C G C G T T T C A A T T C C C T T T T G A A A A C A A C T T Q C A A G A A A A T G T T 
1951 G C T G G T A T G G C T T G T C A G T A T G T G A G G A G C G T G A T C T C A T C A G T T C A A C G 
2001 T G T T G C A A T G G C G A T C T C A C C G T C T G G G A T A A G C C C G A G T C T G Q G C T C C A 
2051 A A T T G T C C C C A G G A T C T C C T G A A G C T G T T A C T C T T G C T C A G T Q G A T C T C T 
2101 C A A A G T C A C A G T C A T C A C T T A G G C T C G G A G TTGCTGACGA T T G A T T C A C T 
2151 T Q G A A G C G A C G A C T C G G T A C TAAAACTTCT ATGGGATCAC CAftGATGCCA 
2201 TCCTGTGTTG C T C A T T A A A G CCACAGCCAG T G T T C A T G T T T G C G A A C C A A 
2251 G C T G G T C T A G A C A T G C T A G A G A C A A C A C T T GTAGCXTTTAC A A G A T A T A A C 
2301 A C T C G A A A A G A T A T T C G A T G A A T C G Q G T C G T A A G G C T A T C T G T T C G G A C T 
2351 T C G C C A A Q C T A A T G C A A C A G G G A T T C G C T C GCTTGCCTTC A G G A A T C T G T 
2401 G T G T C A A C G A T G G G A A G A C A T G T G A G T T A T G A A C A A G C T G T T G C T T G G A A 
2451 A G T G T T T G C T G C A T C T G A A G A A A A C A A C A A C A A T C T G C A T TGTCTTGCCT 
2501 TCTCCTTTGT AAACTGGTCT TTTGTGTGA 
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REV cDNA compared wrtti two published sequences 
10 20 30 40 50 60 
I I I I I I 
bnt ig# 1 
| r i a • S MEMAVANHRERSSDS^raRHLDSSGKYVRYTAEQVEM£RVYAECPKPSSIJ«QQLIRECSIIJU^l 
R CDNA MEMAVANHRERSSDSMNRHIJ)SSGKYWYTAEQVEM£RWAECPKPSSIJ«IQQLIRECSILANIEPK 
c lone MEMAVANHRERSSDShlNRHIJJSSGKYWYTAEQVEAI^WAECPKPSSIJaiQQLIRECSIIJ^^ 
70 80 90 100 110 120 130 
I I I I I I I 
in t i g# 1 I 
x i a ' s QIKVWFQNRSVRDKQRKEASRI^SVNRKLSAMhnOJ^ENDMiQKQVSQLVCENGYMRQQPTO 
IR CDNA QIKVWFQNRRCRDKQRKEASRI^SVNiya.SAMNKIJJffiENDRLQKQVSQLVCENGyMKQQLT^^ 
m. c lone QIKVWFQNRSVRDKQRKEASRI^SVNRKLSAMNKIJJtEENDRIX3KQVSQLVCENGYMRQQI^^ 
140 150 160 170 180 190 200 
I I I I I I I 
in t ig# 1 
i r i a • s SCESVVTTPQHSIJlDANSPAGIiSIAEETIAEFLSKATGTAVDWVQMPGMKPGPDSVGIFAISQRCNG 
IR CDNA SCESVVTTPQHSIJU)ANSPAGLLSIAEETU^FLSKATGTATOWVC»lP<aiK^ 
WA c lone SCESVVTm}HSIJlDANSPAGIiSIAEETIJ^FLSKATGTAVDWQMP(aiKPGPDSVGIFAISQRCNG 
210 220 230 240 250 260 270 
I I I I I I I 
i n t i g # 1 
x i a ' S VAARACGLVSLEPMKIAEIIJUJRPSWFRDCRSI^OTTMFPAGNGGTIELVYMQTYAPTTI^ 
JR CDNA VAARACGLVSI£PMKIAEIIJ^DRPSWFRDCRSLEWTOFPAGNGGTIELVyMQTYAPTTIJ«>A^ 
m. Clone VAARACGLVSI^PMKIAEII^RPSWFRDCRSIiOTTOFPAGNGGTIELVYMQTYAPTriJ^ARDFOT 
280 290 300 310 320 330 340 
I I I I I I I 
i n t i g # 1 
r i a • s LRYTTSLDNGSFWCERSLSGSGAGPNAASASQFVRAEMLSSGYLIRPCDGGGSIIHIVDHLNLEAWS 
IR CDNA LRnTSLDNGSFWCERSLSGSGAGPNAASASQFVRAEMLSSGYLIRPCDGGGSIIHIVDHLNLEAWS 
NA Clone LJIYTTSLDNGSFVVCERSLSGSGAGPNAASASQFVRAEMLSSGYLIRPCDGGGSIIHIVDHLNLEAWS 
350 360 370 380 390 400 
I I I I I I 
n t i g # 1 
r i a ' S VPDVLRPLYESSKWAQKMTI SAIJ^Y IRQLAQESNGEVVYGI/»QPAVIJ*TFS(»UiSRGFNDAVNGre 
IR CDNA VPDVIJ«>LYESSKWAOKMTISAIJRYIROIJ^QESNGEVWGIX»QPAVIJlTFS<»lLSRGFNDAV^ 
NA c lone VPDVXJ^PLYESSKWAQKMTISALRYIRQLAQESNGEVVYGLGRQPAVLRTFSQRLSRGFNnAVNGFG 
410 420 430 440 450 460 470 
I I I I I I I 
n t i g # 1 
r i a ' S DDGWSTMHCDGAEDIIVAINSTKHIJmiSNSI^FI^GVIiCAKASMLLQNVPPAVLIRFI^^ 
IR cDNA DDGWSTMHCDGAEDIIVAINSTKHIJWISNSI^FIXX^njCAKASMIiQNVPPAVLIRFIJ*^^ 
NA c lone DDGWSlTOCDGAEDirVAINSTKHIJra iSNSLSFLGGVLCAKASMLIXJNVPPAVLIRFIJ^^ 
480 490 500 510 520 530 540 
I I I I I I I 
n t i g # 1 
r i a ' S FNVDAYSAATIjyVGSFAYPQlRPTRFTGSQIIMPUJHTIEHEEJO^VVRIJEGHSIAQ 
IR CDNA FNVDAYSAATIJWGSFAYP<31RPTRFTGSQIIMPX£HTIEHEEMLEVVRLEGHSIAQEDAFMS^ 
NA c lone FNVDAYSAATLKAGSFAYPOmPTRFTGSQIIMPLGHTIEHEEMIJ^n/RI^HSIAQEDAFMSRDV^ 
550 560 570 580 590 600 610 
I I I I I I I 
fctig# 1 
I r i a ' s I^ICTGIDENAVGACSELIFAPINEMFPDDAPLWSGFRVIPVDAKTGDVQDLLTANHRTLDLTSSLE 
l l R cDNA LQICTGIDENAVGACSELIFAPINEMFPDDAPLVPSGFT^VIPVDAKTCDVQDIiTANHRTLDLTSSLE 
1^ c lone LQICTGIDENAVGACSELIFAPINEMFPDDAPLVPSGFTlVIPVDAKTGDVQDIiTAinmTLDLTFSLE 
620 630 640 650 660 670 680 
I I I I I I I 
t i g # 1 
t i a • S VGPSPENASGNSFSSSSSRCILTIAFQFPFENNLQENVAQIACQYVRSVISSVCSIVAMAISPSGISPS 
ER cDNA VGPSPENASGNSFSSSSSRCILTIAFQFPFENNLQENVAGMACQYVRSVISSVQRVAMAISPSGISPS 
K A c lone VGPSPENASGNSFSSSSSRCILTIAFQFPFENKLQENVAOiACQyVRSVISSVt^lVAMAISPSGISPS 
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690 700 710 720 730 740 
I I I I I I ntig# 1 
r i a ' s IX;Sia.SPGSPEAVTIAQWISQSYSHHIX3SELLTIDSLGSDDSVIJaiWDHQDAIIx;CSIja^PVFM^ 
IR cDNA I^SKLSPGSPEAVTIAQWISQSYSHHLGSEIiTIDSIX3SDDS\rtjajJWDHQDAII^CSIJU>QPVF^ 
NA clone LGSKI^PGSPEAVTIAQWISQSHSHFn/;SEIiTIDSIX3SDDSVIJaiWDHQDMU;CSUCPQPVrMFA 
750 760 770 780 790 800 810 
I I I I I I I ntig# 1 
r i a ' s NQAGLimETTLVAI^DITUIKIFDESGRKAICSDFAKLMQQGFACLPSGICVSTMGRHVSYEQAVAW 
IR cDNA NQAGL[mETTLVAr/3DITU:KIFDESGRKAICSDFAKLMQCX5FACIJSGIC:VST»«ayjVSYEQAVAW 
NA clone NQAGri»D^TTLVAI/3DITI^IFDESGRJU^ICSDFAKIJ*3QGFARIJ'SGICVS™^^ 
820 830 
I I ntig# 1 
r i a' s KVFAASEENNNNLHCLAFSFVNWSFV 
IR cDNA KVFAASEENNNNLHCLAFSFVNWSFV 
NA clone KVFAASEENNNNLHCLAFSFVNWSFV 
66 
6.2. Appendix B - Constructs and Vectors 
• pCR®II-TOPO® Plasmid 
• pMP N-link GFP 
<• pACN (circular) 
• pACN:GFP(N) 
pSRNACNbin (circular) 
• pSRNSCNbin (linearised) 
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Map of pCR*ll-TOPO* 
pCR'll-TOPO* 
Map 
The map bdow shows the features of pCR'*II-TOPO' and ihe sequence surrounding the 
TOPO* Cloning site. Restriction sites are labeled lo indicate the actual cleavage site. The 
arrows indicate the start of transcription for Sp6 and T7 polymerases. For the full 
sequence of the vector, vou mav download it from our web site or call Technical Service 
(page 19). 
Ml 3 Rovff3< Pnmef 
C A G C A A ACA O C T i l S A O : 
G T C C 7 T T C - C G A T A G T O G 
^ T T .\C'Z : C A A G C TOT T T A G G T G A G A C T A T A O A A 
T A A T G C G G T T C G . V T A A A T C C A C T G T G A T A T q:~ 
T A G T C A AGG T A T G C A : 
A T G A G T T C G A T A C G T ; 
aaX I ecoR ) 
G C G A G T G T G C T G GAA 
C G G T C A C A C G A G C T T AAG 
AGC T C G G A T C C A C T A G T A A C G 
T T G A'GC C T A G G T G A T C A T T G C 
PstJ 
: C C G A A T T E T G C A C J A T A T 
T C C C G : T T A A G A C C T C T A T A 
aax I ; na\ 
1 
C C A T C A C A C T G G C G G 
G C T A G T C T G A C C 'GCC 
. ! . G A G G G C C C A A T T C G fcCC T A T 
T C T r r C G G G T T A A G C | G G G A T A 
y 13 1.20". =orw4rd Pnmof 
M13(-»0) FomnS Pnnwt 
G T C 3 T T T T A ' iHA C G T C G T G A C T G G G A A A A C 
: A G C . A A A A T OTT G C S G C A C T G A C C C T T T T G 
A C T GAG T C G T A T T.»C 
^ G C A T A A T P 
pCR»ll-TOPO® 
3.9 kb Comments for pCR*II-TOPO* 3950 nucleotides 
LacZo gene: bases I -588 
MI3 Reverse priming site: bases 205-221 
Sp6 promoter: bases 239-256 
Multiple Cloning Site: bases 269-399 '.^  
T7 promoter: bases 406-J25 
M13 (-20) Forward pnmmgsite: bases 433-44S 
Ml3 (-40) Forward priming site: bases 453-468 
n ongm: bases 590-1004 
Kanamycin resistance ORf: bases 1338-2132 
Ampicillin resistance ORF: bases 2150-3010 
pUC origin: bases 3155-3828 
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pMP-Nlink GFP 
Modified GFP sequence with N-terminal linker and two unique multiple cloning sites; one for upstream promoter insertion and 
one for downstream N-terminal protein fusion. The Nos Terminator also has a choice of downstream restriction sites for 
transfer of the whole cassette into pCIRCE. The backbone is a high copy number vector, modified from the Clontech pEGFP-1 
plasmid (Kan R). The completed protein fusion may be transferred into pCIRCE using 5' Bgl I I (ends compadble with 
BamHl) , BamHl , Smal, K p n l , Sacl, Hind I I I or EcoRl, coupled with sites from downstream Nos. NB ; Hindl l l site is not 
unique, being found in the 5' MCS and downstream of Nos. 
5' MCS N-terminal MCS 
Bel 1 (BamHl compatible end) 
Esp31 (EcoRI compatible end) 
Si 
Oral 
(blunt) 
Hind HI* 
5'MCS 
Xmal 
hc<>47III XM. Hindlll* PstL SacU Smai' A L V I 1 
TACTA(iC(}C'rACCGGACTrA(>A I Q O 1A( ;( Tt -AACKTrO iAAT I ( TGCACnCGAO W i I A<TGC(KKi(XXta(;c;Ar<'< A< ( (.(; ICGCCACC A liiiG 
Hi;l II S.w\ Fo'KI Kpn i Apal Ham H1 Ncol 
fci I II Asp^lSI Bsp 1201 
N-terminal MCS 
STOP ^ BstXl 
Pviil SnaBl Spel Not l EcoRV (Kpi i Icompatibie eiul) 
G C A . C r G . T A C A l A T G C . C ; A r . C ( ; T . A C G . T A A . C r A G T T A A G G G C G A A T T T A C A A G T A A A r , C G G ( C G ^ 
Linker BsrGI Ndel 
T 
N B stop codon in frame between SnaBl and Spel sites. 
1 3 7 1 9 
prBla-01-01 (99 bp) 
cAmp-02 (861 bp) pACN 
4024 bp 
pry^A-01-01 (270 bp) 
cCAT-01-01 (660 bp) 
tNOS-05-01 (253 bp) 
prLacZ-01-01 (122 bp) 
oCOLE-06-01 (807 bp) 
o 
pACN:GFP(N) 
This construct is derived from pACN(Pst) and comprises the ALCA promoter (270bps) driving the mpGFP 
from pMP-Nlink GFP (Mags 2006). Following insertion of a C-terminal sequence( at the SnaB1 site)the 
whole insert can only be moved as a Hind3 fragment into pSRNACNbin, therefore if a Hind3 site is present 
in the gene to be linked to the GFP then this construct should not be used and the gene inserted directly into 
pSRNACNbin:GFP. All inserts should be cloned into the SnaB1 site (blunt) to be upstream of the STOP 
codon (TAA). Check that the insert is in frame! 
Hind3 Pst Nco1 ATG 
i Prom ALC i i 
pACN( fo r ) " ^ 270bps T 
Age1 
mpGFP(for) pACN(rev) Hind3 
mpGFP Linke^ 
mpGFP(rev>/ g^agy 
359bps 
100bps 
852bps 
N O S T 
t 
EcoR1 
GCA.CTG.TAC.ATA.TGC.GAT.CGT A C G lAA CTAGTT 
(SnaB1) (STOP) 
cTetr-01-01 (651 bp) 
ocole-03-01 (316 bp)^ 
cTraJ-01 (372 bp)^ ^ 
ork2-01-01(618bp) ^ 
prNpt3-01 (377 bp) 
PJH0022 
cNpt3-01-02 (795 bp) 
cTrfA-01 (1149 bp) 
bNKB-U1-U2(1b2 bp) 
bNRB-01-01 (25 bp) 
prNos-04-02 (299 bp) 
cNpt2-04-01 (822 bp) 
" lNOS-03-01 (254 bp) 
pr35s-04-01 (521 bp) 
Hmd 111 
Hinci III 
pSRNACNbin 
16515 bp 
cAlcR-08 (2466 bp) 
tNOS-06-01 (251 bp) 
prALCA-01-01 (270 bp) 
cCAT-01-01 (660 bp) 
tNOS-05-01 (253 bp) 
bNLB-01-01 (25 bp) 
bNLB-01-02 (148 bo) 
pACN (Pst) 
This construct is derived from pACN and comprises the ALGA promoter (270bps) and the Nos terminator 
The only site available is Pst. The cassette can be removed as a H3 fragment into pSRNACNbin(-CAT). 
Hind3 Pst 
Prom ALC i 
pACNjrev Hind3 
HOST 
pACN(for) ^ T 
pUC based 
Amp^ 
2 7 0 b p 2 5 0 b p 
EcoR1 
pSRNACNbin(-CAT) 
This construct is derived from pSRNACNbin, and is based on BIN 19 (Kan^ 
R B 
Hind3 
353 i AlcR -MOST Prom ALC 
Pst HindS 
I I L B 
JLj NOS T 1-1^ 
pSRNACN(for)2 
2 7 0 b p 2 5 0 b p 
pSRNACN{rev) 
pAI(bin)NGFP 
RB 
H/nc/3 
3 5 S - A l c R 
D S R A C N ^ } 
pSRACN(for\l 
P r o m A L C p y m p G F P iLinkeff 
E C ^ V pSRNACM(r6v) 
N O S T 
S n a B f 250bp 
270bp 
359bps 
LB 
N O S T 
G C A . C T G . T A C . A T A . T G C . G A T . C G T A C G T A A C T A G T T 
(SnaB1) (STOP) 
6.3. Appendix C - Protocols 
• Expand High Fidelity PGR System 
• RNeasy Plant Mini Protocol 
<* Wizard® Plus SV Minipreps DNA Purification System - Promega 
• High Pure PGR Product Purification Kit - Roche 
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For general laboratory use. 
FOR IN vmO USE ONLY. 
E x p a n d H i g h F i d e l i t y P C R S y s t e m J ? ; 
eoxynucleoside-triphosphate: DNA deoxynucleotidyttransferase, EC. 2.7.7.7 -e^^cL 
at. No. 1 7 3 2 641 lOO U for approx. 40 reactions 
a t No. 1 7 3 2 650 500 U C2 x 250 U] for approx. 200 reactions 
at. No. 1 7 5 9 0 7 8 2500 U (10 x 250 U3 for approx. 1000 reactions 
Version 4. Feb. 2003 
- 1 5 to - 2 5 ° C S t a b l e at 
Yxhict o v e r v i e w Enzyme properties 
vial Contont 
1 Expand High 
Fidelity 
Enzyme mix 
• 30 Ml ('00 U pack size) 
• 2x 72 pi C500 U pack size) 
• lOx 72 ul (2500 U pack size) 
Enzyme storage buffer. 20 mfvi 
Tris-HCI. pH 75 (25"0. 100 mf^ 
KCI. 1 mM dithlothreitol (DTT). 
O.t mM EDTA. 0.5% Nonidei P40 
{»/v). 0.5% Tween 20 (v/v). 
50% glycerol (v/v) 
2 Expand High 
Fidelity 
buffer. lOX 
cone, witfi 
15 mM 
• 1 ml (100 U pack size) 
• 2x 1 ml (500 U pack size) 
• 10X I ml C2500 U pack size) 
3 Expand High 
Fidelity 
buffer, l o x 
iMna with-
out MgOj 
• 1 ml 000 U pack size) 
• 1 ml (500 U pack size) 
• 1 ox 1 ml (2500 U pack size) 
M9Q2 stock 
solution: 
25 mM 
• 1 ml 0 OO U pack size) 
• 1 ml (500 U pack size) 
• lOx 1 ml (2500 U pack size) 
C-C- C-rX,<-
Volume activity 
Error rate" 
Optimal enzyme con-
centration 
Standard enzyme con-
centration 
Optimal elongation 
temperature 
Optimal 
traiion 
Standard Mg'" 
cenuation 
PCR product size 
PCR cloning 
Repair of mismatched 
primers at 3" end 
Incorporation of modi-
fied nucleotides 
Prevention ol cany-
over contamination 
3.5 U/| 
approx. 4.8 x I C * 
varies from 0.5-5 U per 50 pi 
reaction 
2.6 U (0.75 mO per 50 pi raac-
tion 
7 r C . For PCR products >3 kb 
the optimal elongation tem-
perature is 68*0. 
varies from 1.5 -
MgCI,] 
4 mM (as 
1.5 mM (as M g C y v»hen 
using 200 pM dMTP eacli 
up to 5 kb 
TA-cloning 
yes. due to the 3'-S' exonu-
cJease activity of the proof-
reading polymerase 
accepts modified nucleotides 
like DIG-dUTP. biotin-dtJTP. 
fluorescein-dUTf^ 
no 
oduct 
scription 
orageand 
sbiHiy 
splj cations 
Expand High Fidelity PCR System is composed of a 
unique enzyme mix containing thermostable Taq DNA 
polymerase and Tgo DNA potymerase. a thermostable 
DNA potymerase with proofreading aciivny. This pow-
erlul potymemse mixture is designed to generate PCR 
products of high yieW- high fidelity and high specificixy 
from an types of DNA OX Expand High Fidelity PCR 
^ s t e m is especial^ optimized to efficientt>' amplify 
DNA fragment3 up to 5 kb. PCR is possible up to 9 kb 
with yield diminishing as DNA fragment length 
increasea 
For the generation of longer PCR products, the Expand 
Long Template PCR System, which is optimized (or the 
amplification of DNA fragments ranging from 3 kb to 
27 kb in length, is recommended. 
Due to the injierwii 3'-5' exonuclease or ^iroolread-
'.na- a p * " ^ 0* Tgo'O^A j^ymerase . t'hejideijty of 
DNA synthesis with ExpartfT^iofi FideTity PGR System 
ferror rate aoprox. 4 6 x IQ'* ) snows a 3-fold increa&g_ 
mmparp^ tn Tnq pNA polymerase [error rate apprpx. 
- Retatjve fidetity determined by the lad essay (2). 
~ For ganemtiT^g probes For Southern anolyais the corKentra-
lion of modified dl/TP should bo 50 pM (with tSO ^W tSTTP). 
When using ftuorescein-dUTP the MgOj concentration 
shook) be incraased to * mM. For ELISA based detection 
systems e concentiatton oMO pM modiTwd dUTP is suffi-
oeni. 
~ Unlobeted dlTTP OnsiBsd of OTTP) is a poor substrate forthe 
Expand enzyme mi*. Therefore it is not reconwnended to use 
the Expand enzym* mix in combination Mith UNG corry over 
pf^vemion. 
Standard PCR procedure 
Gimenrf 
Stable at -15 to -25X until the control date primed on 
the label 
Polymerase Chain Reaction (PGR) 
DNA labeling reactions 
The optimal conditions (incubation times and tempera-
tures, concentrations of enzyme, template DNA. Mg^^ 
depend on the system used and have to be determined 
individually. In particular, the Mg ' * concentration and 
the amount of Expand enzyme mix used per assay 
should be titrated for opUmat efficiency of DNA syn-
thesis. 
As a staning poinL use the followtng gutdeftnes: 
^ Optimal eruyme concentration: a s - S U/50 pi- The 
recommended starting concentration is i 6 U 
(0.75 pa 
- Optimal Mg^ **^  concentratitHi can vary from 1.5-
4 mM. The recommendtid starting concentration b 
1.5 mM when using 200 pM dNTP (each). 
• aNJP concentration: always use balanced solutions 
of all four dNTP. The final concentration of each 
dhnP should be between 50 and 500 pM: the most 
commonly used concentration is 200 pM. Incr^se 
concentrations of Mg *^*" when increasing the con-
centration of dNTP. 
Cn7Z7UlO 
< S e > 
76 
T>ie optimal bu»er for ihe lemplaie DNA is either 
simply sterile dojble-distilled water or 5-10 mM Tris 
(pH 7-8). Avoid dissolving the template m TE buffer 
because EDTA chelates Mg'* . 
Usually ii is not necessary to add additives. Never-
theless in some cases improvements can be 
achieved by using up to 100 pg/ml bovine serum 
albumin (BSA). 0.1«» Tween 20 (v/v) or l-2it DIVISO. 
eparation o( Por a larger number_ol reactions, we recommend that 
action mixes ' you prepare two reacti6n~mixes. This circumvems the 
need of -Hot h\an- and avoids that the_3 -5>xpni>_ 
ctease activity of the progfieadinq potyrner^se partially 
"degrades primers and template dunng the reaaion 
~Tet-uP; 
It is also recommended to prepare a f^aster Mix for 
setting up multiple reaaions. TTie IVIasier Mix typically 
contains all of ttie components needed for all PCR 
tests to be performed at a volume 10% greater than 
that required for the total number of PCR assays. 
s o p A o l o n 
1 I Briefly vortex and centrifuge all reagents oefore 
starting. 
Prepare VMO mixes of reagents in sterile 
microfuge tubes (on ice): 
Mix 1 flor one reaaion) 
Reagent Votume RnaJ c o n e 
sterita double-
dtsL water 
add up to 
25 pi 
Deoxynucieo-
ttde mix 
(10 mM oteach 
dhfTP) 
1 Ml 200 pM of 
each dNTP 
Upsiream 
primer 
variable 300 nM t 
Downstream 
primer 
variable 300 nM i 
1 
Template DNA variable 0.1 - i 
250 ng^ I 
Final vohimo 25*11 i 
Mix 2 (for one reaaion) 
Reagent Volume Final c o n e 
sterile double-
disL water 
1925 Ml 
Expand High 
Fidelity buffer. 
lOx cone, with 
15 mM MgO^ 
5 Ml IX 
(1.5 mM 
Expand High 
Fidelity enzyme 
mtx 
0.75 M' 2.5 
reaaion 
Rna l volume 25 Ml 1 
i-When titrating ihe Mg^* concemraiion 
use the Expand High Rdelity buffer. lOx cona 
without MgO^ and ihe MgCU slock soKjDon 
(25 wMl 
' Combine Mn l ana Mbt 2 in a ihin-walled 
PCR tube (on ice). 
• Gently vortex the mixture to produce a 
homogeneous reection. men centrifuge 
briafV to collect sample at tne bonom oi the 
tube 
I ^ Vjoffl; Overlay ihe reaaion carefully with min-
eral oil i* required by your type of ifiennal 
I cycler. 
• e.g. human genomic DNA temowie: 10 ng-250 ng; iM«am«) 
DNA lemoiato: 0,1 ng - J5 og. 
Thermal c y d i n g Place samples in the thermal cycler, anc sian cycling 
using Ihe thermal profile below. The gradually increas-
ing extension lime ensures a higher yield of amplifica-
tion products. ^ 
' ntote: The elongation step should be performed at 
e S * C when PGR products longer than 3 kb are ampli-
Temp. [ Time Cycle 
No. 
Initial 
denatu ration 
2 min 1 X 
Denatu ration 
Annealing 
Elongation 
9 « 
T T C o r 
S8'C= 
15s 
30 s 
45 s - 8 mm" 
10 X 
Denaturatnn 
Annealing 
Elongation 
9 4 X 15s 
30 s 
45 s - 8 min'' + 
5 s cycle elong-
ation for each 
successive 
cycle' 
1 5 -
20 X 
Final 
elongation 
T T C 7 min 1 X 
Cooling 4-C unlimited time 
" optimal annealing lemperBUiro depends or the melting 
tampamtu™ of the pnmeii and on in* system uaed 
Far PCR products up to 3 k& olongailon umperBtum shouW 
Cw at 77*C: for PCR prttducts larger than 3 kb olongouon 
tempetetum stwutd be ot 6e*C 
" Elongation om« dopenos on fmgment length. 41 • for uo to 
a73 kti. 1 min for 1.5 kb. 2 mm tor 3 U). « min for S kb. 8 mtn 
tor 10 U>. 
' For sumpla. cycto no. 11 is S b lonQor man cyde 10. cyeift na 
12 is 10 1 longer Iftancyda lO.cyctano. 13 is 15 s longer 
tnan cycU i a « c 
Afpffi; The ihermat profiles were developed for the 
Applied Biosystems GeneAmp PCR System 9600. Other 
thermal cyclere may require different profiles. 
Trouble shooting 
Uttle or no P C R 
product 
Possible 
cause 
R ecommendstion 
Difficult tem-
plate eg. G C -
rich templates 
• Use the GC-RICH PCR System. 
• Perform initial denaruratton step at 
9 5 T for 3 - 5 min. 
Poor DNA 
template 
quality 
Check quality and concentration of 
iemi>iate: 
• Analyze an aliquot on an agarose 
gei to checK for possible degrada-
tion. 
• Make a control reaction on tem-
plate with an established primer 
pair or PCR system. 
• Check or repeat punfication of 
template. 
Enzyme con-
centration too 
low 
Increase the amount of enzyme mix m 
0.5 U steps. 
MgO} con-
centration too 
low 
Increase Ute MgCl? concenirotion m 
steps of 025 mM. 0-5 mM MgO? is 
me mtnimat concentration.) 
Cycle condi-
tions not opti-
mal 
• Reduce anneating temperature. 
• Irtcrease cycle number. 
• Make sure that the final etongation 
step vwas carried out 
Primer design 
not optimal 
Design alternative pnmers. 
IPrimer con-
centration not 
optimal 
• Both pnmers must have the same 
concentration. 
• Titrate pnmer concentration (0.2 -
0.6 uM\ 
Annealing 
lemoeraturB 
too high 
• Reduce annealing temperature 
(minimal annealing temperature is 
ftST). 
• Detcrmme tr»c optimal annealing 
temperature by toucfi-down PCR. 
conoTMjed on next oage 
Roche Appliai Science 
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ol ice lo A license under U.S. Palenis 4,683.202. 4.683.195, and 
u rchaser 4,965.188 or (heir foreign counlerparts. owned by 
Roche Moteciilar Systems. Inc. and F. Hoffmann-La 
Roche Ltd fRoche") . has an up-front fee component 
and a running-royalty componenL The purchase price 
of this product includes limited, nontransferable rights 
under the running-royalty component to use only this 
amount of the product to practice the Polymerase 
Chain Reaction f ' P C R T and related processes 
described in said palenis solef/ (or the rasoarch and 
development adrvities of the purchaser when this 
product is used in conjunction with a thermal cyder 
whose use is covered by the up-front fee component 
Rights to the up-lroni fee component must be 
obtained by the end user in order to have a complete 
license to use this product in the PGR process. These 
rights under the up-front fee component may be pur-
chased from Applied Biosystems or obtained by pur-
chasing an Authorized Tfienral Cycler. No right to 
perlorm or offer commercial services ol any kind using 
PGR. including without limitaiion reporting the results 
of purchaser's activities for a tee or other commercial 
consideration, is heretty granted by implication or 
estoppel. Further information on purchasing licenses to 
practice the PCR Process may be obtained by conian-
ing the Director of Licensing at Applied Biosystems. 
850 Lincoln Centre Drive. Foster City. California 94404 
or the Licensing DepanmenL Roche Molecular Sys-
tems, Inc., 1145 Atlantic Avenue. Alameda, California 
94501, 
) w to contact Roch« Applied Science 
w w w . r o c h e - a p p l l e d - s c l e n c e . c a i n 
to order, solve technical queries, find produa information, 
or contact your local sales represematn/e. 
www.roche-app l led -sc ience .con i /pac l ( - inse f t /1732641a4>dt 
< \ Roche Diagnostics GmbH Roche > Science 
82372 Penzberg 
Gennany 
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RNeasy Plant Mini Protocol for Isolation of Total RNA from Plant 
Cells and Tissues, and Filamentous Fungi 
Important notes before starting 
• Total RNA isolation from plant cells and tissues and filamentous fungi requires the 
RNeasy Plant Mini Kit and cannot be performed with the RNeasy Mini Kit alone. 
• A maximum of 100 mg plant material or 1 x 10?cells can be used per preparation. 
See "How much starting material can I use?" (page 12) for more information. 
• If using RNeasy for the first time, please read "Disruption and homogenization of 
starting materials" (page 16). 
• If preparing RNA for the first time, please read Appendix A (page 54). 
• The RNeasy Plant Mini Kit provides two different lysis buffers. Buffer RLT and Buffer 
RLC, which contain guanidine isothiocyanate (GITC) or guanidine hydrochloride 
(GuHCI), respectively. In most cases Buffer RLT is the lysis buffer of choice due to the 
greater cell disruption and denaturation properties of GITC. However, depending 
on the amount and type of secondary metabolites in some tissues (such as milky 
endosperm of maize or mycelia of filamentous fungi), GITC can cause solidification 
of the sample, making extraction of RNA impossible. In these cases Buffer RLC should 
be used, 
• Buffer RPE is supplied as a concentrate. Before using for the first time add 4 volumes 
of ethanol (96-100%) as indicated on the bottle to obtain a working solution, 
• Buffer RLT may form a precipitate upon storage. If necessary, warm to redissolve. 
• P-Mercaptoethanol (P-ME) must be added to Buffer RLT or Buffer RLC before use (see 
page 20), Add 10 \s\ P-ME per 1 ml of Buffer RLT or Buffer RLC. The solution is stable 
for 1 month. 
• The time between harvesting of tissue and freezing should be minimized. Once 
tissue is frozen, do not allow to thaw. 
• After disruption, all steps of the RNeasy protocol should be performed at 20 to 
25°C. During the procedure, work quickly. 
• All centrifugation steps should be performed in a microcentrifuge at 20 to 25°C. 
46 RNeasy Mini Handbook 05/99 
1. Grind sample under liquid nitrogen to a fine powder using a mortar and pestle. 
Transfer the tissue powder and liquid nitrogen to an appropriately sized tube, and 
allow the liquid nitrogen to evaporate. Do not allow the sample to thaw. Continue 
immediately with step 2. 
Note: Incomplete grinding of the starting material will lead to reduced RNA yields. 
2. Add 450 pi of either Buffer RLT or Buffer RLC (see notes above) to a maximum of 
100 mg of tissue powder. Vortex vigorously. 
A short (1-3 min) incubation at 56°C may help to disrupt tissue. However for samples 
with high starch content, incubation at elevated temperatures should be omitted to 
prevent swelling of the starting material. 
Note: Ensure p-ME is added to Buffer RLT or Buffer RLC before use (see "Important 
notes before starting"). 
3. Apply lysate to the QIAshredder spin column (lilac) sitting in a 2-ml collection tube, 
and centrifuge for 2 min at maximum speed. Transfer flow-through fraction from 
QIAshredder to a new tube (not supplied) without disturbing the cell-debris pellet in 
the collection tube. 
It may be necessary to cut the end off the pipet tip to apply the lysate to the QIAshredder 
spin column. This centrifugation through QIAshredder removes cell debris and 
simultaneously homogenizes the lysate. While most of the cell debris is retained on 
the QIAshredder spin column, a very small amount of cell debris will pass through 
and fonri a pellet in the collection tube. Be careful not to disturb this pellet while 
transferring the lysate to a new tube (not supplied). 
4. Add 0.5 volumes (usually 225 pi) ethanol (96-100%) to the cleared lysate and mix 
well by pipetting. 
If some lysate is lost during homogenization, reduce volume of ethanol proportionally. 
A precipitate may form after the addition of ethanol, but this will not affect the RNeasy 
procedure, 
*See optional step listed at the end of this protocol, 
5. Apply sample (usually 675 pi), including any precipitate which may have formed, 
onto an RNeasy mini spin column (pink) sitting in a 2-ml collection tube. Centrifuge for 
15 sec at >8000 x g (>10,000 rpm). 
If the volume of the mixture exceeds 700 pi, load aliquots successively onto the 
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RNeasy column and centrifuge as above. Reuse the same collection tube but discard 
flow-through* after each step. Reuse the collection tube in step 6. 
' Flow-through contains Buffer RLT and is therefore not compatible with bleach, 
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6. Pipet 700 pi Buffer RW1 onto the RNeasy column, and centrifuge for 15 sec at 
>8000 X g (>10,000 rpm) to wash. 
Discard flow-through* and collection tube. 
7. Transfer RNeasy column into a new 2-ml collection tube (supplied). PIpet 500 pi 
Buffer RPE onto the RNeasy column, and centrifuge for 15 sec at >8000 x g 
(>10,000 rpm). 
Discard flow-through and reuse the collection tube in step 8. 
Note: Ensure ethanol is added to Buffer RPE before use (see "Important notes before 
starting"). 
8. Add 500 pi Buffer RPE to the RNeasy column, and centrifuge for 2 min at maximum 
speed to dry the RNeasy membrane. Continue directly with step 9, or to eliminate 
any chance of possible Buffer RPE carryover, continue first with step 8a. 
It is important to dry the RNeasy membrane since residual ethanol may interfere with 
subsequent reactions. This spin ensures that no residual ethanol will be carried over 
during elution. Discard flow-through and collection tube. 
Note: Following the spin, remove the RNeasy column from the collection tube 
carefully so that the column does not contact the flow-through as this will result in 
carryover of ethanol. 
8a. (Optional): Place the RNeasy spin column in a new 2-ml collection tube (not 
provided), and discard the old collection tube with the filtrate. Centrifuge at full speed 
for 1 min. 
9. Transfer RNeasy column into a new 1.5-ml collection tube (supplied), and pipet 
30-50 pi of RNase-free water directly onto the RNeasy membrane. Centrifuge for 
1 min at >8000 x g (>10,000 rpm) to elute. Repeat if the expected RNA yield is 
>20 pg. 
If a second elution step is performed, elute into the same collection tube using another 
30-50 Ml RNase-free water. 
• Flow-through contains Buffer RW1 and is therefore not compatible with bleach 
* DNase Step (Optional) 
a. Add 10|jl DNase solution from Qiagen RNase-Free DNase Set to 70|jl buffer RDD from same and mix 
gently without vortexing. 
b. Add the BOpI DNase mix to the membrane taking care to avoid any of the mix sticking to the sides. 
c. Incubate at room temperature for 15 minutes. 
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High Pure PCR Product Purification Kit - Roche 
2.3 Purification of PCR Products in Solution after Amplification 
In the following protocol the purification of PCR products in solution after 
amplification is described. 
L To process a larger sample (>100 J ) , either increase proportionally the 
amount of Binding Buffer (Step 1), or divide the larger sample into several 
100 J aliquots and process each as a separate sample. 
_ After PCR is complete, adjust total volume for each PCR tube (reaction 
components + DNA product) to 100 J : 
• Add 500 J Binding Buffer to each 100 J PCR tube. 
N Mineral oil or wax do not need to be removed from the PCR solution 
before adding the Binding Buffer. 
• Mix sample (Binding Buffer + PCR solution) well. 
_ • Insert one High Pure Filter Tube into one Collection Tube. 
• Transfer the sample from step 1 using a pipette to the upper reservoir 
of the Filter Tube. 
• Centrifuge 30 - 60 s at maximum speed in a standard table top centrifuge 
at+15 to +25°C. 
_ • Disconnect the Filter Tube, and discard the flowrthrough solution. 
• Reconnect the Filter Tube to the same Collection Tube. 
_ • Add 500 J Wash Buffer to the upper reservoir. 
• Centrifuge 1 min at maximum speed (as above). 
_ • Discard the flowrthrough solution. 
• Recombine the Filter Tube with the same Collection Tube. 
• Add 200 J Wash Buffer. 
• Centrifuge 1 min at maximum speed (as above). 
N This second 200 J wash step ensures optimal purity and complete 
removal of Wash Buffer from the glass fibers. 
_ • Discard the flowthrough solution and Collection Tube. 
• Reconnect the Filter Tube to a clean 1.5 ml microcentrifuge tube. 
_ • Add 50- 100 J Elution Buffer to the upper reservoir of the Filter Tube. 
• Centrifuge 1 min at maximum speed. 
N Do not use water for elution since alkaline pH is required for optimal 
yield. 
_ The microcentrifuge tube now contains the purified DNA. 
N When subsequent OD260 determination is planned, centrifuge the 
eluate for more than 1 min at maximum speed to remove residual 
glass fibers from the eluate, because they may disturb absorbance 
measurement. Use an aliquot of the supernatant to determine 
concentration. 
L Either use the eluted DNA directly or store the eluted DNA at +2 
to +8°C or_15 to _25°C for later analysis. 
2.4 Purification of DNA Fragments from Agarose Gel 
In the following table the purification procedure for DNA from a 100 mg agarose 
gel slice is described: 
_ Isolate DNA band of interest electrophoretically as follows. 
• Load PCR reaction mixture on a 0,8 - 2% agarose gel. 
• Use 1 X TAE or 1 x TBE as running buffer. 
• Electrophorese until DNA band of interest is isolated from adjacent 
contaminating fragments 
_ Identify bands by staining gel with ethidium bromide or SYBR Green I 
Nucleic Acid Gel Stain*. 
N Wear gloves, ethidium bromide is a known potent carcinogen. 
_ Cut desired DNA band from gel using an ethanol-cleaned scalpel or 
razor blade. 
N Minimize gel volume by visualizing DNA and cutting the smallest 
possible gel slice on a UV light box. 
_ • Place excised agarose gel slice in a sterile 1.5 ml microcentrifuge tube. 
• Determine gel mass by first pre-weighting the tube, and then reweighting 
the tube with the excised gel slice. 
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_ Add 300 J Binding Buffer for every 100 mg agarose gel slice to the 
microcentrifuge tube. 
_ • Dissolve agarose gel slice in order to release the DNA: 
• Vortex the microcentrifuge tube 15 - 30 s to resuspend the gel slice in 
the Binding Buffer. 
• Incubate the suspension for 10 min at 56°C. 
• Vortex the tube briefly every 2 - 3 min during incubation. 
_ After the agarose gel slice is completely dissolved: 
• Add 150 J isopropanol for every 100 mg agarose gel slice to the 
tube. 
• Vortex thoroughly. 
_ • Insert one High Pure Filter Tube Into one Collection Tube. 
• Pipette the entire contents of the microcentrifuge tube into the upper 
reservoir of the Filter Tube. 
N Do not exceed 700 J total volume. If mixture is > 700 J , split the 
volume and use two separate Filter Tubes for each portion. 
Centrifuge 30 - 60 s at maximum speed in a standard table top centrifuge 
at+15 to +25X. 
• Discard the flo/rthrough solution. 
• Reconnect Filter Tube with the same Collection Tube. 
_ • Add 500 J Wash Buffer to the upper reservoir. 
• Centrifuge 1 min at maximum speed (as above). 
_ • Discard the flowthrough solution. 
• Recomblne Filter Tube with the same Collection Tube. 
•Add 200 J Wash Buffer. 
• Centrifuge 1 min at maximum speed. 
L This second 200 J wash step ensures optimal purity and complete 
removal of Wash Buffer from the glass fibers. 
• Discard the flowthrough solution and Collection Tube. 
• Recombine Filter Tube with a clean 1.5 ml microcentrifuge tube. 
_ • Add 50 - 100 J Elution Buffer to the upper reservoir of the Filter Tube. 
• Centrifuge 1 min at maximum speed. 
_ The microcentrifuge tube now contains the purified DNA. 
N When subsequent O D 2 6 0 determination is planned, centrifuge the 
eluate for more than 1 min at maximum speed to remove residual 
glass fibers from the eluate, because they may disturb absorbance 
measurement. Use an aliquot of the supernatant to detenmine 
concentration. 
L Either use the eluted DNA directly or store the eluted DNA at +2 
to +8°C or_15 to _25°C for later analysis. 
www.roche-applied-science.com 
'available from Roche Applied Science 
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